Benjamin Movsas

Q: What Schools Are Affiliated With Benjamin Movsas

Benjamin Movsas is affiliated with the following schools: Medical College of Wisconsin, Johns Hopkins University, University of Toronto, Temple University, Thomas Jefferson University, University of Pennsylvania

Benjamin Movsas's AcademicInfluence.com Rankings

Benjamin Movsas

Medical

#2645

World Rank

#3076

Historical Rank

Oncology

#168

World Rank

#174

Historical Rank

medical Degrees

Benjamin Movsas

Philosophy

#7606

World Rank

#10843

Historical Rank

Logic

#4652

World Rank

#5970

Historical Rank

philosophy Degrees

Download Badge

Medical
Philosophy

Why Is Benjamin Movsas Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Benjamin Movsas's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Sequential vs. concurrent chemoradiation for stage III non-small cell lung cancer: randomized phase III trial RTOG 9410. (2011) (983)
Androgen suppression adjuvant to definitive radiotherapy in prostate carcinoma--long-term results of phase III RTOG 85-31. (2005) (921)
Randomized trial of short- versus long-course radiotherapy for palliation of painful bone metastases. (2005) (731)
Treatment of non-small cell lung cancer stage I and stage II: ACCP evidence-based clinical practice guidelines (2nd edition). (2007) (461)
Dose escalation with 3D conformal treatment: five year outcomes, treatment optimization, and future directions. (1998) (434)
Randomized trial of hypofractionated external-beam radiotherapy for prostate cancer. (2013) (406)
Pulmonary radiation injury. (1997) (331)
Phase III comparison of sequential vs concurrent chemoradiation for pts with unresected stage III non-small cell lung cancer (NSCLC): Report of Radiation Therapy Oncology Group (RTOG) 9410 (2000) (325)
Validation and predictive power of Radiation Therapy Oncology Group (RTOG) recursive partitioning analysis classes for malignant glioma patients: a report using RTOG 90-06. (1998) (325)
Phase III trial of prophylactic cranial irradiation compared with observation in patients with locally advanced non-small-cell lung cancer: neurocognitive and quality-of-life analysis. (2011) (318)
Stereotactic body radiation therapy for early-stage non-small cell lung cancer: Executive Summary of an ASTRO Evidence-Based Guideline. (2017) (310)
A randomized phase III study of accelerated hyperfractionation versus standard in patients with unresected brain metastases: a report of the Radiation Therapy Oncology Group (RTOG) 9104. (1997) (306)
Consideration of dose limits for organs at risk of thoracic radiotherapy: atlas for lung, proximal bronchial tree, esophagus, spinal cord, ribs, and brachial plexus. (2011) (293)
Dosimetry and preliminary acute toxicity in the first 100 men treated for prostate cancer on a randomized hypofractionation dose escalation trial. (2006) (270)
Higher biologically effective dose of radiotherapy is associated with improved outcomes for locally advanced non-small cell lung carcinoma treated with chemoradiation: an analysis of the Radiation Therapy Oncology Group. (2012) (254)
Partial volume tolerance of the spinal cord and complications of single‐dose radiosurgery (2007) (253)
Treatment of Small-Cell Lung Cancer: American Society of Clinical Oncology Endorsement of the American College of Chest Physicians Guideline. (2015) (245)
Radiation pulmonary toxicity: from mechanisms to management. (2010) (236)
Primary analysis of a phase II randomized trial Radiation Therapy Oncology Group (RTOG) 0212: impact of different total doses and schedules of prophylactic cranial irradiation on chronic neurotoxicity and quality of life for patients with limited-disease small-cell lung cancer. (2011) (225)
Incorporating clinical measurements of hypoxia into tumor local control modeling of prostate cancer: Implications for the α/β ratio (2003) (207)
Randomized trial of amifostine in locally advanced non-small-cell lung cancer patients receiving chemotherapy and hyperfractionated radiation: radiation therapy oncology group trial 98-01. (2005) (197)
Hypoxic prostate/muscle pO2 ratio predicts for biochemical failure in patients with prostate cancer: preliminary findings. (2002) (191)
Dose delivered from Varian's CBCT to patients receiving IMRT for prostate cancer (2007) (189)
Hypoxic regions exist in human prostate carcinoma. (1999) (178)
Palliative thoracic radiotherapy in lung cancer: An American Society for Radiation Oncology evidence-based clinical practice guideline (2011) (175)
RTOG 0631 phase 2/3 study of image guided stereotactic radiosurgery for localized (1-3) spine metastases: phase 2 results. (2014) (173)
Correlates of tobacco use among smokers and recent quitters diagnosed with cancer. (2002) (167)
Quality of life supersedes the classic prognosticators for long-term survival in locally advanced non-small-cell lung cancer: an analysis of RTOG 9801. (2009) (166)
Conformal technique dose escalation for prostate cancer: biochemical evidence of improved cancer control with higher doses in patients with pretreatment prostate-specific antigen > or = 10 NG/ML. (1996) (165)
Measurement of intrafractional prostate motion using magnetic resonance imaging. (2002) (156)
Defining Local-Regional Control and Its Importance in Locally Advanced Non-small Cell Lung Carcinoma (2012) (152)
Salvage reirradiation for recurrent glioblastoma with radiosurgery: radiographic response and improved survival (2008) (148)
Decline in tested and self-reported cognitive functioning after prophylactic cranial irradiation for lung cancer: pooled secondary analysis of Radiation Therapy Oncology Group randomized trials 0212 and 0214. (2013) (148)
Phase I trial of replication-competent adenovirus-mediated suicide gene therapy combined with IMRT for prostate cancer. (2007) (146)
Pain control by image-guided radiosurgery for solitary spinal metastasis. (2008) (144)
Phase I study of noninvasive imaging of adenovirus-mediated gene expression in the human prostate. (2008) (136)
Quality of Life Analysis of a Radiation Dose-Escalation Study of Patients With Non-Small-Cell Lung Cancer: A Secondary Analysis of the Radiation Therapy Oncology Group 0617 Randomized Clinical Trial. (2016) (135)
Increasing levels of hypoxia in prostate carcinoma correlate significantly with increasing clinical stage and patient age (2000) (128)
Stereotactic body radiation therapy for primary, recurrent, and metastatic tumors in the head-and-neck region. (2009) (128)
Radiosurgical decompression of metastatic epidural compression (2010) (127)
Chronic rectal bleeding after high-dose conformal treatment of prostate cancer warrants modification of existing morbidity scales. (1997) (124)
The benefit of treatment intensification is age and histology-dependent in patients with locally advanced non-small cell lung cancer (NSCLC): a quality-adjusted survival analysis of radiation therapy oncology group (RTOG) chemoradiation studies. (1999) (122)
Efficacy of a belly board device with CT-simulation in reducing small bowel volume within pelvic irradiation fields. (1997) (119)
Hypoxia in Human Prostate Carcinoma: An Eppendorf Po2 Study (2001) (113)
Familial cancer associated with a polymorphism in ARLTS1. (2005) (107)
A phase III study of conventional radiation therapy plus thalidomide versus conventional radiation therapy for multiple brain metastases (RTOG 0118). (2008) (104)
Transoral resection of pharyngeal cancer: Summary of a National Cancer Institute Head and Neck Cancer Steering Committee Clinical Trials Planning Meeting, November 6–7, 2011, Arlington, Virginia (2012) (102)
Five-year follow-up of trial of replication-competent adenovirus-mediated suicide gene therapy for treatment of prostate cancer. (2007) (101)
Implementation of a novel algorithm for generating synthetic CT images from magnetic resonance imaging data sets for prostate cancer radiation therapy. (2015) (101)
Is there an increased risk of second primaries following prostate irradiation? (1998) (99)
Treatment of stage II non-small cell lung cancer. (2003) (98)
Characteristics of cancer patients entering a smoking cessation program and correlates of quit motivation: implications for the development of tobacco control programs for cancer patients (2004) (98)
Longitudinal predictors of continued tobacco use among patients diagnosed with cancer (2003) (97)
Increasing levels of hypoxia in prostate carcinoma correlate significantly with increasing clinical stage and patient age: an Eppendorf pO(2) study. (2000) (94)
Quality of life in oncology trials: a clinical guide. (2003) (88)
Dosimetric verification and clinical evaluation of a new commercially available Monte Carlo-based dose algorithm for application in stereotactic body radiation therapy (SBRT) treatment planning (2010) (87)
Combining scatter reduction and correction to improve image quality in cone-beam computed tomography (CBCT). (2010) (85)
The relationship of increasing radiotherapy dose to reduced distant metastases and mortality in men with prostate cancer (2004) (83)
Phase I study of thoracic radiation dose escalation with concurrent chemotherapy for patients with limited small-cell lung cancer: Report of Radiation Therapy Oncology Group (RTOG) protocol 97-12. (2005) (82)
Importance of the mini-mental status examination in the treatment of patients with brain metastases: a report from the Radiation Therapy Oncology Group protocol 91-04. (2000) (81)
Radiosurgery to the surgical cavity as adjuvant therapy for resected brain metastasis. (2012) (81)
Incorporating clinical measurements of hypoxia into tumor local control modeling of prostate cancer: implications for the alpha/beta ratio. (2003) (80)
2D/3D image fusion for accurate target localization and evaluation of a mask based stereotactic system in fractionated stereotactic radiotherapy of cranial lesions. (2006) (79)
Symptom clusters in patients with head and neck cancer receiving concurrent chemoradiotherapy. (2013) (78)
Issues and challenges with integrating patient-reported outcomes in clinical trials supported by the National Cancer Institute-sponsored clinical trials networks. (2007) (77)
Evaluation of multiple image-based modalities for image-guided radiation therapy (IGRT) of prostate carcinoma: a prospective study. (2013) (76)
Increased hypoxia correlates with increased expression of the angiogenesis marker vascular endothelial growth factor in human prostate cancer. (2001) (76)
Hypoxic prostate/muscle PO2 ratio predicts for outcome in patients with localized prostate cancer: long-term results. (2012) (76)
RTOG 0631 Phase II/III Study of Image-Guided Stereotactic Radiosurgery for Localized (1-3) Spine Metastases: Phase II Results. (2011) (75)
Activation of glnA transcription by nitrogen regulator I (NRI)-phosphate in Escherichia coli: evidence for a long-range physical interaction between NRI-phosphate and RNA polymerase (1989) (74)
Response of non-Hodgkin lymphoma to radiation therapy: early and long-term assessment with H-1 MR spectroscopic imaging. (1995) (73)
Prospective randomized phase 2 trial of intensity modulated radiation therapy with or without oncolytic adenovirus-mediated cytotoxic gene therapy in intermediate-risk prostate cancer. (2014) (73)
Prostate cancer gene therapy clinical trials. (2007) (70)
Randomized phase II chemotherapy and radiotherapy trial for patients with locally advanced inoperable non-small-cell lung cancer: long-term follow-up of RTOG 92-04. (2002) (70)
Evidence of increased failure in the treatment of prostate carcinoma patients who have perineural invasion treated with three‐dimensional conformal radiation therapy (1997) (70)
Pretreatment quality of life predicts for locoregional control in head and neck cancer patients: a radiation therapy oncology group analysis. (2008) (68)
Conformai external beam treatment of prostate cancer (1997) (67)
Role of prostate dose escalation in patients with greater than 15% risk of pelvic lymph node involvement. (2005) (61)
Recommended patient-reported core set of symptoms to measure in head and neck cancer treatment trials. (2014) (61)
Metastatic Meningioma to the Lung With Multiple Pleural Metastases (2001) (60)
Replication-competent adenovirus-mediated suicide gene therapy with radiation in a preclinical model of pancreatic cancer. (2007) (60)
Magnetic Resonance-Based Automatic Air Segmentation for Generation of Synthetic Computed Tomography Scans in the Head Region. (2015) (58)
Management of Radiation Toxicity in Head and Neck Cancers. (2017) (57)
Technical and Clinical Experience with Spine Radiosurgery: A New Technology for Management of Localized Spine Metastases (2007) (57)
Phase I dose escalating trial of hyperfractionated pre-operative chemoradiation for locally advanced rectal cancer. (1998) (57)
Disadvantage of men living alone participating in Radiation Therapy Oncology Group head and neck trials. (2006) (57)
Radiosurgery Compared To External Beam Radiotherapy for Localized Spine Metastasis: Phase III Results of NRG Oncology/RTOG 0631 (2019) (56)
A finite element method to correct deformable image registration errors in low-contrast regions (2012) (55)
Induction paclitaxel and carboplatin followed by concurrent chemoradiotherapy in patients with unresectable, locally advanced non-small cell lung carcinoma: report of Fox Chase Cancer Center study 94-001. (1997) (55)
Automatic Segmentation of the Prostate on CT Images Using Deep Neural Networks (DNN). (2019) (54)
A technique of using gated-CT images to determine internal target volume (ITV) for fractionated stereotactic lung radiotherapy. (2006) (54)
Radiotherapy patterns of care study in lung carcinoma. (2003) (54)
Can physicians accurately predict survival time in patients with metastatic cancer? Analysis of RTOG 97-14. (2008) (54)
Radiation-Induced Fibrosis: Mechanisms and Opportunities to Mitigate. Report of an NCI Workshop, September 19, 2016. (2017) (54)
Pooled Analysis of Individual Patient Data on Concurrent Chemoradiotherapy for Stage III Non-Small-Cell Lung Cancer in Elderly Patients Compared With Younger Patients Who Participated in US National Cancer Institute Cooperative Group Studies. (2017) (53)
Penetration of recommended procedures for lung cancer staging and management in the United States over 10 years: a quality research in radiation oncology survey. (2013) (53)
Single fraction spine radiosurgery for myeloma epidural spinal cord compression. (2009) (53)
Effect of amifostine on survival among patients treated with radiotherapy: a meta-analysis of individual patient data. (2011) (52)
Emotional well‐being does not predict survival in head and neck cancer patients (2008) (51)
Prospective evaluation of quality of life and neurocognitive effects in patients with multiple brain metastases receiving whole-brain radiotherapy with or without thalidomide on Radiation Therapy Oncology Group (RTOG) trial 0118. (2008) (51)
PROceeding With the Patient-Reported Outcomes (PROs) Version of the Common Terminology Criteria for Adverse Events. (2015) (51)
Comparing cancer patients who enroll in a smoking cessation program at a comprehensive cancer center with those who decline enrollment (2004) (50)
The Influence of Gender, Race, and Marital Status on Survival in Lung Cancer Patients: Analysis of Radiation Therapy Oncology Group Trials (2010) (50)
Study of paclitaxel, etoposide, and cisplatin chemotherapy combined with twice-daily thoracic radiotherapy for patients with limited-stage small-cell lung cancer: a Radiation Therapy Oncology Group 9609 phase II study. (2005) (49)
Biochemical failure as a determinant of distant metastasis and death in prostate cancer treated with radiotherapy. (2003) (48)
Examining margin reduction and its impact on dose distribution for prostate cancer patients undergoing daily cone-beam computed tomography. (2008) (48)
Age-related prostate cancer metastases. (1998) (48)
Image-guided localization accuracy of stereoscopic planar and volumetric imaging methods for stereotactic radiation surgery and stereotactic body radiation therapy: a phantom study. (2011) (47)
Pretreatment factors significantly influence quality of life in cancer patients: a Radiation Therapy Oncology Group (RTOG) analysis. (2006) (47)
Feasibility of adenovirus-mediated hNIS gene transfer and 131I radioiodine therapy as a definitive treatment for localized prostate cancer. (2011) (46)
Clinically meaningful differences in patient-reported outcomes with amifostine in combination with chemoradiation for locally advanced non-small-cell lung cancer: an analysis of RTOG 9801. (2008) (46)
Dosimetric evaluation of synthetic CT relative to bulk density assignment-based magnetic resonance-only approaches for prostate radiotherapy (2015) (46)
Primary cardiac sarcoma: a novel treatment approach. (1998) (45)
A phase III comparison of radiation therapy with or without recombinant beta-interferon for poor-risk patients with locally advanced non-small-cell lung cancer (RTOG 93-04). (2002) (45)
Evaluation of the deformation and corresponding dosimetric implications in prostate cancer treatment (2012) (45)
Radiation pneumonitis and esophagitis in thoracic irradiation. (2006) (44)
On the impact of smoothing and noise on robustness of CT and CBCT radiomics features for patients with head and neck cancers (2017) (44)
Impact of fraction size on lung radiation toxicity: hypofractionation may be beneficial in dose escalation of radiotherapy for lung cancers. (2010) (44)
Radiation esophagitis: Predictive factors and preventive strategies. (2004) (43)
MRI simulation: effect of gradient distortions on three-dimensional prostate cancer plans. (2002) (43)
Analysis of the Factors Contributing to Vertebral Compression Fractures After Spine Stereotactic Radiosurgery. (2015) (43)
Patient-reported outcomes and survivorship in radiation oncology: overcoming the cons. (2014) (43)
Treatment Design and Rationale for a Randomized Trial of Cisplatin and Etoposide Plus Thoracic Radiotherapy Followed by Nivolumab or Placebo for Locally Advanced Non-Small-Cell Lung Cancer (RTOG 3505). (2017) (43)
Outcomes toolbox for head and neck cancer research (2015) (43)
Who enrolls onto clinical oncology trials? A radiation Patterns Of Care Study analysis. (2007) (42)
Which patient will feel down, which will be happy? The need to study the genetic disposition of emotional states (2010) (41)
Effect of amifostine on response rates in locally advanced non-small-cell lung cancer patients treated on randomized controlled trials: a meta-analysis. (2007) (41)
Effect of advanced age on outcome in Radiation Therapy Oncology Group studies of locally advanced NSCLC (LA-NSCLC) (2000) (41)
Phase II radiation therapy oncology group trial of weekly paclitaxel and conventional external beam radiation therapy for supratentorial glioblastoma multiforme. (2001) (40)
Clinical commissioning and use of the Novalis Tx linear accelerator for SRS and SBRT (2012) (40)
A Phase II Study of Concurrent Carboplatin and Paclitaxel and Thoracic Radiotherapy for Completely Resected Stage II and IIIA Non-small Cell Lung Cancer (2007) (40)
Radiotherapy Patterns of Care Study in Lung Carcinoma (2003) (39)
ACR Appropriateness Criteria® nonsurgical treatment for locally advanced non-small-cell lung cancer: good performance status/definitive intent. (2014) (38)
Decreasing the Adverse Effects of Cancer Therapy: National Cancer Institute Guidance for the Clinical Development of Radiation Injury Mitigators (2010) (38)
Evaluation of residual patient position variation for spinal radiosurgery using the Novalis image guided system. (2008) (38)
A method for increased dose conformity and segment reduction for SMLC delivered IMRT treatment of the prostate. (2003) (37)
Contouring variability of human- and deformable-generated contours in radiotherapy for prostate cancer (2015) (37)
Health related quality of life and cognitive status in patients with glioblastoma multiforme receiving escalating doses of conformal three dimensional radiation on RTOG 98-03 (2009) (37)
Quantifying radiation therapy-induced brain injury with whole-brain proton MR spectroscopy: initial observations. (2001) (36)
Correlation of dose computed using different algorithms with local control following stereotactic ablative radiotherapy (SABR)-based treatment of non-small-cell lung cancer. (2013) (36)
Evaluation of a magnetic resonance guided linear accelerator for stereotactic radiosurgery treatment. (2018) (35)
ACR appropriateness criteria nonsurgical treatment for non-small-cell lung cancer: poor performance status or palliative intent. (2009) (34)
Quality of Life in Patients With Low-Risk Prostate Cancer Treated With Hypofractionated vs Conventional Radiotherapy: A Phase 3 Randomized Clinical Trial (2019) (34)
ACR Appropriateness Criteria for external beam radiation therapy treatment planning for clinically localized prostate cancer, part II of II (2017) (34)
Consensus statement on palliative lung radiotherapy: third international consensus workshop on palliative radiotherapy and symptom control. (2012) (34)
Evaluating organ delineation, dose calculation and daily localization in an open-MRI simulation workflow for prostate cancer patients (2015) (34)
Development and clinical evaluation of a three-dimensional cone-beam computed tomography estimation method using a deformation field map. (2012) (33)
Impact of Marital Status on Survival Among Women With Invasive Cervical Cancer: Analysis of Population-Based Surveillance, Epidemiology, and End Results Data (2010) (33)
Androgen suppression adjuvant to radiotherapy in carcinoma of the prostate. long-term results of phase III RTOG study 85-31 (2003) (33)
Long-term visual changes following pituitary irradiation. (1995) (32)
Cisplatin, ifosfamide, oral etoposide, and concurrent accelerated hyperfractionated thoracic radiation for patients with limited small-cell lung carcinoma: results of radiation therapy oncology group trial 93-12. (2000) (32)
Patterns of care survey (PCS) in lung cancer: how well does current U.S. practice with chemotherapy in the non-metastatic setting follow the literature? (2005) (32)
Daily target localization for prostate patients based on 3D image correlation. (2004) (32)
Can electronic web-based technology improve quality of life data collection? Analysis of Radiation Therapy Oncology Group 0828. (2014) (32)
Stereotactic IMRT for prostate cancer: Dosimetric impact of multileaf collimator leaf width in the treatment of prostate cancer with IMRT (2004) (31)
Phase III randomized trial of 8 Gy in 1 fraction vs. 30 Gy in 10 fractions for palliation of painful bone metastases: preliminary results of RTOG 97-14 (2003) (31)
Outcomes Research in Cancer Clinical Trial Cooperative Groups: The RTOG Model (2004) (31)
Characteristics of a novel treatment system for linear accelerator–based stereotactic radiosurgery (2015) (30)
Quality-of-life outcomes in oncology. (2006) (30)
ACR appropriateness criteria: Permanent source brachytherapy for prostate cancer. (2017) (29)
Real-time Magnetic Resonance-guided Liver Stereotactic Body Radiation Therapy: An Institutional Report Using a Magnetic Resonance-Linac System (2019) (29)
Quality of Life (QOL) Analysis of the Randomized Radiation (RT) Dose-Escalation NSCLC Trial (RTOG 0617): The Rest of the Story (2013) (28)
Development and evaluation of a clinical model for lung cancer patients using stereotactic body radiotherapy (SBRT) within a knowledge‐based algorithm for treatment planning (2016) (28)
ACR Appropriateness Criteria® Noninvasive Clinical Staging of Primary Lung Cancer. (2019) (28)
Evaluation of gantry speed on image quality and imaging dose for 4D cone-beam CT acquisition (2016) (28)
Conformal external beam treatment of prostate cancer. (1997) (28)
Comparison of Similarity Measures for Rigid-body CT/Dual X-ray Image Registrations (2007) (28)
Marking Hypoxia in Rat Prostate Carcinomas with β-d-[125I]Azomycin Galactopyranoside and [99mTc]HL-91: Correlation with Microelectrode Measurements (2001) (27)
Stereotactic IMRT for prostate cancer: Setup accuracy of a new stereotactic body localization system (2004) (27)
ACR Appropriateness Criteria® external beam radiation therapy treatment planning for clinically localized prostate cancer, part I of II (2016) (27)
Impact of marital status and race on outcomes of patients enrolled in Radiation Therapy Oncology Group prostate cancer trials (2012) (26)
Improvements in CBCT Image Quality Using a Novel Iterative Reconstruction Algorithm: A Clinical Evaluation (2019) (26)
An adaptive MR-CT registration method for MRI-guided prostate cancer radiotherapy (2015) (26)
Quantification of incidental dose to potential clinical target volume (CTV) under different stereotactic body radiation therapy (SBRT) techniques for non-small cell lung cancer - tumor motion and using internal target volume (ITV) could improve dose distribution in CTV. (2007) (26)
Morphologic magnetic resonance imaging features of therapy-induced cerebral necrosis (2010) (26)
Impact of gender, partner status, and race on locoregional failure and overall survival in head and neck cancer patients in three radiation therapy oncology group trials. (2011) (26)
Computed tomography-magnetic resonance image fusion: a clinical evaluation of an innovative approach for improved tumor localization in primary central nervous system lesions. (1997) (26)
The impact of concurrent granulocyte–macrophage colony-stimulating factor on quality of life in head and neck cancer patients: results of the randomized, placebo-controlled Radiation Therapy Oncology Group 9901 trial (2014) (26)
The addition of amifostine to carboplatin and paclitaxel based chemoradiation in locally advanced non-small cell lung cancer: long-term follow-up of Radiation Therapy Oncology Group (RTOG) randomized trial 9801. (2013) (26)
Effects of prescription depth, cylinder size, treatment length, tip space, and curved end on doses in high-dose-rate vaginal brachytherapy. (2007) (26)
A research agenda for radiation oncology: results of the radiation oncology institute's comprehensive research needs assessment. (2012) (26)
Qualitative Assessment of Academic Radiation Oncology Department Chairs' Insights on Diversity, Equity, and Inclusion: Progress, Challenges, and Future Aspirations. (2018) (26)
Risk factors for clinician‐reported symptom clusters in patients with advanced head and neck cancer in a phase 3 randomized clinical trial: RTOG 0129 (2014) (25)
Application of radiomics for prediction of HPV status for patients with head and neck cancers. (2019) (24)
International practice survey on palliative lung radiotherapy: third international consensus workshop on palliative radiotherapy and symptom control. (2010) (24)
Prostate cancer patient subsets showing improved bNED control with adjuvant androgen deprivation. (1997) (24)
Initial clinical experience with a radiation oncology dedicated open 1.0T MR‐simulation (2015) (24)
NCCN practice guidelines for upper gastrointestinal carcinomas (1959) (24)
A technique of quantitatively monitoring both respiratory and nonrespiratory motion in patients using external body markers. (2007) (24)
FMEA of MR-Only Treatment Planning in the Pelvis (2018) (24)
NRG oncology RTOG 9006: a phase III randomized trial of hyperfractionated radiotherapy (RT) and BCNU versus standard RT and BCNU for malignant glioma patients (2018) (24)
Analyzing predictive models following definitive radiotherapy for prostate carcinoma (1997) (24)
ACR appropriateness criteria on nonsurgical treatment for non-small-cell lung cancer: poor performance status or palliative intent. (2009) (23)
Phase I/II trial of a COX-2 inhibitor with limited field radiation for intermediate prognosis patients who have locally advanced non-small-cell lung cancer: radiation therapy oncology group 0213. (2011) (23)
Adaptive seamless design for an efficacy trial of replication-competent adenovirus-mediated suicide gene therapy and radiation in newly-diagnosed prostate cancer (ReCAP Trial). (2011) (23)
Utility of the ACE Inhibitor Captopril in Mitigating Radiation-associated Pulmonary Toxicity in Lung Cancer: Results From NRG Oncology RTOG 0123 (2016) (22)
Exploring the role of the radioprotector amifostine in locally advanced non-small cell lung cancer: Radiation Therapy Oncology Group trial 98-01. (2002) (22)
An assessment of PTV margin based on actual accumulated dose for prostate cancer radiotherapy (2013) (22)
Amifostine as mucosal protectant in patients with locally advanced non-small cell lung cancer (NSCLC) receiving intensive chemotherapy and thoracic radiotherapy (RT): results of the radiation therapy oncology group (RTOG) 98–01 study (2003) (21)
To gate or not to gate - dosimetric evaluation comparing Gated vs. ITV-based methodologies in stereotactic ablative body radiotherapy (SABR) treatment of lung cancer (2016) (21)
Development and evaluation of a clinical model for lung cancer patients using stereotactic body radiotherapy (SBRT) within a knowledge-based algorithm for treatment planning. (2016) (21)
The surgical management of superior sulcus tumors: a retrospective review with long-term follow-up. (2005) (21)
A novel approach for evaluation of prostate deformation and associated dosimetric implications in IGRT of the prostate. (2014) (21)
Capturing the patient perspective: patient-reported outcomes as clinical trial endpoints. (2012) (21)
Phase II Trial of Preoperative Chemoradiation With a Hyperfractionated Radiation Boost in Locally Advanced Rectal Cancer (2006) (20)
Imaging Response in Malignant Glioma, RTOG 90-06 (2007) (20)
107 Increasing levels of hypoxia in human prostate carcinoma correlate significantly with increasing clinical stage and age: An Eppendorf p02 study (1999) (20)
Prostate localization on daily cone-beam computed tomography images: accuracy assessment of similarity metrics. (2010) (20)
Processes of change related to smoking behavior among cancer patients. (2002) (20)
Evaluation of adaptive treatment planning for patients with non-small cell lung cancer (2017) (19)
Phase I trial of oncolytic adenovirus-mediated cytotoxic and interleukin-12 gene therapy for the treatment of metastatic pancreatic cancer (2020) (19)
Decreasing the Adverse Effects of Cancer Therapy: An NCI Workshop on the Preclinical Development of Radiation Injury Mitigators/Protectors (2011) (18)
Stereotactic body radiotherapy as salvage treatment for recurrence of non-small cell lung cancer after prior surgery or radiotherapy. (2018) (18)
Gender, Professional Experiences, and Personal Characteristics of Academic Radiation Oncology Chairs: Data to Inform the Pipeline for the 21st Century. (2019) (18)
Focusing on the "Person" in Personalized Medicine: The Future of Patient-Centered Care in Radiation Oncology. (2016) (17)
ACR Appropriateness Criteria® noninvasive clinical staging of bronchogenic carcinoma. (2010) (17)
Higher BED is Associated with Improved Local-regional Control and Survival for NSCLC Treated with Chemoradiotherapy: An RTOG Analysis (2005) (17)
ACR Appropriateness Criteria® on Induction and Adjuvant Therapy for Stage N2 Non-Small-Cell Lung Cancer: expert panel on radiation oncology-lung. (2010) (17)
Prospective health-related quality of life valuations (utilities) of 8 Gy in 1 fraction vs 30 Gy in 10 fractions for palliation of painful bone metastases: Preliminary results of RTOG 97–14 (2004) (17)
ACR Appropriateness Criteria® Early-Stage Non–Small–Cell Lung Cancer (2014) (17)
A TCP model incorporating setup uncertainty and tumor cell density variation in microscopic extension to guide treatment planning. (2010) (17)
Age dramatically impacts on the quality-adjusted time without symptoms or toxicity (Q-Twist) in locally advanced non-Small cell lung cancer (LA-NSCLC)-a radiation therapy oncology group (RTOG) analysis (2000) (16)
ACR Appropriateness Criteria® Radiation Therapy for Small-Cell Lung Cancer (2013) (16)
Patterns of practice in radiation therapy for non-small cell lung cancer among members of the American Society for Radiation Oncology. (2014) (16)
Analysis of outcomes in radiation oncology: an integrated computational platform. (2009) (16)
Patterns of Practice in Radiation Dose Prescription and Treatment Planning for Patients With Lung Cancer Among Members of American Society of Therapeutic Radiology and Oncology (2007) (16)
ACR Appropriateness Criteria® Postoperative Adjuvant Therapy in Non-Small Cell Lung Cancer (2011) (16)
Detection of Dominant Intra-prostatic Lesions in Patients With Prostate Cancer Using an Artificial Neural Network and MR Multi-modal Radiomics Analysis (2019) (16)
Initial Validation and Clinical Experience with 3D Optical-Surface-Guided Whole Breast Irradiation of Breast Cancer (2012) (16)
Evaluation and Clinical Application of a Commercially Available Iterative Reconstruction Algorithm for CBCT-Based IGRT (2019) (16)
Therapeutic enhancement of radiation and immunomodulation by gold nanoparticles in triple negative breast cancer (2021) (16)
Randomized Phase II Trial of Cisplatin, Etoposide, and Radiation Followed by Gemcitabine Alone or by Combined Gemcitabine and Docetaxel in Stage III A/B Unresectable Non-small Cell Lung Cancer (2010) (16)
Amifostine in chemoradiation therapy for non-small cell lung cancer: review of experience and design of a phase II trial assessing subcutaneous and intravenous bolus administration. (2005) (15)
Cultivating Tomorrow's Clinician Scientists: We Reap What We Sow. (2015) (15)
The role of radiation therapy and chemotherapy in the management of airway tumors other than small-cell carcinoma and non-small-cell carcinoma. (2003) (15)
ACR Appropriateness Criteria® Induction and Adjuvant Therapy for N2 Non–small-cell Lung Cancer (2015) (15)
The Complementary Nature of Patient-Reported Outcomes and Adverse Event Reporting in Cooperative Group Oncology Clinical Trials: A Pooled Analysis (NCCTG N0591). (2015) (14)
Development of a standard survivorship care plan template for radiation oncologists. (2016) (14)
ACR Appropriateness Criteria: nonsurgical treatment for non-small-cell lung cancer: good performance status/definitive intent. (2010) (14)
Evaluation and management of elderly patients with lung cancer. (2012) (14)
Characteristics of x-ray beams in two commercial multidetector computed tomography simulators: Monte Carlo simulations. (2011) (14)
Phase II trial of induction high-dose chemotherapy followed by surgical resection and radiation therapy for patients with marginally resectable non-small cell carcinoma of the lung. (2000) (13)
To move or not to move: measurements of prostate motion by urethrography using MRI. (2001) (13)
Imaging to optimally stage lung cancer: conventional modalities and PET/CT. (2004) (13)
Shifting the Focus to Practice Quality Improvement in Radiation Oncology (2010) (13)
Can costs be measured and predicted by modeling within a cooperative clinical trials group? Economic methodologic pilot studies of the radiation therapy oncology group (RTOG) studies 90-03 and 91-04. (2001) (13)
Pharmacologic normal tissue protection in clinical radiation oncology: focus on amifostine (2008) (12)
Practical methods for improving dose distributions in Monte Carlo‐based IMRT planning of lung wall‐seated tumors treated with SBRT (2012) (12)
Dosimetric predictors for acute esophagitis during radiation therapy for lung cancer: Results of a large statewide observational study. (2017) (12)
Dose Escalated Radiotherapy Alone or in Combination With Short-Term Androgen Suppression for Intermediate Risk Prostate Cancer: Outcomes From the NRG Oncology/RTOG 0815 Randomized Trial. (2021) (12)
Conformal external beam treatment of prostate cancer. Commentary (1997) (12)
Treatment of prostate cancer with regional lymph node (N1) metastasis. (2003) (12)
How Often are Previously Undetected Radiographic Abnormalities Detected at the Time of CT Simulation for Breast Cancer Patients? (2009) (12)
Phase III Study of Prophylactic Cranial Irradiation vs. Observation in Patients with Stage III Non–small-cell Lung Cancer: Neurocognitive and Quality of Life Analysis of RTOG 0214 (2009) (11)
Characteristics of a novel treatment system for linear accelerator-based stereotactic radiosurgery. (2015) (11)
Quality-of-life trials in lung cancer: past achievements and future challenges. (2004) (11)
A hypoxic ratio of prostate pO2/muscle pO2 predicts for biochemical failure in prostate cancer patients (2001) (11)
Evaluation of auto-contouring and dose distributions for online adaptive radiation therapy of patients with locally advanced lung cancers. (2022) (11)
Role of Thoracoscopic Lymph Node Staging for Lung and Esophageal Cancer (1996) (10)
Phase II trial of preoperative chemoradiation with a hyperfractionated rt boost in locally advanced rectal cancer (2001) (10)
Utilize target motion to cover clinical target volume (ctv)--a novel and practical treatment planning approach to manage respiratory motion. (2008) (10)
Intrafraction variability and deformation quantification in the breast. (2015) (10)
ACR Appropriateness Criteria® Locally Advanced, High-Risk Prostate Cancer (2017) (10)
Pharmacologic normal tissue protection in clinical radiation oncology: focus on amifostine. (2008) (10)
Developing a radiation error scoring system to monitor quality control events in a radiation oncology department. (2009) (10)
Predictors of Pneumonitis after Conventionally Fractionated Radiotherapy for Locally Advanced Lung Cancer. (2021) (10)
Emotional Intelligence and Burnout in Academic Radiation Oncology Chairs (2017) (10)
Gender differences in pretreatment quality of life in a prospective lung cancer trial. (2008) (10)
VA-Radiation Oncology Quality Surveillance Program. (2020) (10)
American Radium Society™ Appropriate Use Criteria on Radiation Therapy in Oligometastatic or Oligoprogressive Non-Small Cell Lung Cancer. (2021) (9)
Measurement of regional compliance using 4DCT images for assessment of radiation treatment. (2011) (9)
FDG PET Response by 3 Months Following Stereotactic Body Radiotherapy for Non-Small Cell Lung Cancer May be an Early Surrogate of Local Failure (2007) (9)
A prediction model of radiation‐induced necrosis for intracranial radiosurgery based on target volume (2017) (9)
Quality-of-life concerns in lung cancer patients (2010) (9)
A Prospective Phase II Study of Induction Carboplatin and Vinorelbine followed by Concomitant Topotecan and Accelerated Radiotherapy (ART) in Locally Advanced Non-small Cell Lung Cancer (NSCLC) (2007) (9)
Role of adjuvant therapy in resected stage II/IIIA non-small-cell lung cancer. (2002) (9)
SU‐GG‐J‐30: A Novel Scatter Reduction and Correction Method to Improve Cone‐Beam CT (CBCT) Image Quality (2010) (9)
3 Imaging response is highly predictive of survival of malignant glioma patients treated with standard or hyperfractionated RT and carmustine in RTOG 9006 (1996) (9)
Do Sociodemographic Factors Influence Outcome in Prostate Cancer Patients Treated With External Beam Radiation Therapy? (2016) (9)
Intracranial Fibrosarcoma Arising 5 Years after Chemotherapy Alone for Glioblastoma multiforme in a Child (2000) (9)
Randomized phase III trial of concurrent chemoradiation followed by nivolumab or placebo for locally advanced non-small cell lung cancer (NSCLC) (RTOG 3505). (2017) (9)
Cardiac Dose in Locally Advanced Lung Cancer: Results from a Statewide Consortium. (2019) (9)
Radiotherapy (RT) patterns of care study (PCS) in lung carcinoma (2002) (8)
Clinical Use of Dual Image-Guided Localization System for Spine Radiosurgery (2012) (8)
Correlation of normal lung density changes with dose after stereotactic body radiotherapy (SBRT) for early stage lung cancer (2017) (8)
Partner’s Perspective on Long-term Sexual Dysfunction After Prostate Cancer Treatment (2016) (8)
NRG Oncology/Alliance LU005: A phase II/III randomized clinical trial of chemoradiation versus chemoradiation plus atezolizumab in limited stage small cell lung cancer. (2020) (8)
A method for repositioning of stereotactic brain patients with the aid of real-time CT image guidance (2005) (8)
Secondary Endpoints of a Phase II Randomized Trial (RTOG 0212): Impact of Different Total Doses and Schedules of Prophylactic Cranial Irradiation on Chronic Neurotoxicity and Quality of Life for Patients with Limited Disease Small-cell Lung Cancer (2009) (7)
Characteristics of Participation in Patient-Reported Outcomes and Electronic Data Capture Components of NRG Oncology Clinical Trials. (2020) (7)
Image-Guided Target Localization for Stereotactic Radiosurgery:Accuracy of 6D versus 3D Image Fusion (2006) (7)
Introduction: Cancer, aging, and comorbidities. (2012) (7)
Innovative treatment strategies in locally advanced and/or unresectable non-small cell lung cancer. (2000) (7)
A Phase II Randomized Trial with Captopril in Patients Who Have Received Radiation Therapy +/- Chemotherapy for Stage II–IIIB Non–small Cell Lung Cancer and Stage I Central Non–small Cell Lung Cancer, or Limited-stage Small–cell Lung Cancer: RTOG 0123 (2009) (7)
The value of collaboration between thoracic surgeons and radiation oncologists while awaiting evidence in operable stage i non-small cell lung cancer. (2018) (7)
Induction and concurrent paclitaxel/carboplatin every 3 weeks with thoracic radiotherapy in locally advanced non-small-cell lung cancer: an interim report. (2001) (7)
MO‐F‐BRA‐06: Systematic Evaluation of a Deformable Image Registration Algorithm from a Commercial Software Package (2012) (7)
NRG Oncology/RTOG 0415, Phase 3 Noninferiority Study Comparing 2 Fractionation Schedules in Patients With Low-Risk Prostate Cancer: Prostate-Specific Quality of Life Results (2016) (7)
Phase I Study of Radical Thoracic Radiation, Weekly Irinotecan, and Cisplatin in Locally Advanced Non-small Cell Lung Carcinoma (2007) (7)
Randomized Phase III, Double Blind, Placebo-Controlled Study of Prophylactic Gabapentin for the Reduction of Oral Mucositis Pain During the Treatment of Oropharyngeal Squamous Cell Carcinoma. (2021) (7)
Mindless or mindful? Radiation oncologists' perspectives on the evolution of prostate cancer treatment. (2003) (7)
A phase II trial of weekly paclitaxel and conventional radiotherapy for supratentorial glioblastoma multiforme: RTOG 96-02 (1998) (6)
Correlates of distant metastasis and death in prostate cancer patients treated with radiotherapy (2002) (6)
The State of the Science in Patient-Reported Outcomes for Patients with Lung Cancer (2020) (6)
Phase I study of irinotecan (CPT-11), cisplatin (cDDP) and radical thoracic radiation (TRT) in the treatment of locally advanced non-small cell lung carcinoma (NSCLC) (2000) (6)
Postradiotherapy PSA nadirs fail to support dose escalation study in patients with pretreatment PSA values < 10 ng/ml. (1997) (6)
Patterns of missing mini mental status exam (MMSE) in radiation therapy oncology group (RTOG) brain cancer trials (2011) (6)
Radiation dose-fractionation effects in spinal cord: comparison of animal and human data (2015) (6)
How Vital are Patient Reported Outcomes? (2021) (6)
Evaluation of missing quality of life assessments patterns in radiation therapy oncology group (RTOG) trials (2008) (6)
284 Induction paclitaxel (TAXOL) and carboplatin (CBDCA) followed by concurrent chemoradiotherapy (TRT-CT) in unresectable, locally advanced non-small cell lung carcinoma (NSCLC): Report of FCCC 94-001 (1997) (6)
Cellular Uptake and Radio-sensitization Effect of Small Gold Nanoparticles in MCF-7 Breast Cancer Cells (2018) (6)
Influence of Residual Disease Following Surgical Resection in Newly Diagnosed Glioblastoma on Clinical, Neurocognitive, and Patient Reported Outcomes (2019) (6)
Randomized trial of amifostine in locally advanced non-small cell lung cancer (NSCLC) patients receiving chemotherapy and hyperfractionated radiation (HRT): Long-term survival results of Radiation Therapy Oncology Group (RTOG) 9801 (2007) (6)
American Radium Society™ , Appropriate Use Criteria on Radiation Therapy for Extensive-stage Small Cell Lung Cancer. (2020) (6)
Principal component analysis modeling of Head‐and‐Neck anatomy using daily Cone Beam‐CT images (2018) (6)
American Radium Society™ Appropriate Use Criteria: Radiation Therapy for Limited-stage Small Cell Lung Cancer 2020. (2020) (6)
A model for optimizing adenoviral delivery in human cancer gene therapy trials. (2007) (6)
Morphological Analysis of Tumor Regression and Its Impact on Deformable Image Registration for Adaptive Radiotherapy of Lung Cancer Patients (2015) (5)
Low Morbidity and Excellent Local Control using Image Guided Stereotactic Body Radiotherapy (IGSBRT) for Lung Tumors (2008) (5)
Abuse versus neglect: a model to understand the causes of and treatment strategies for mistreatment of older persons. (1990) (5)
Future directions in palliative thoracic radiotherapy (2012) (5)
Response during radiotherapy may be associated with outcome in mediastinal Hodgkin's disease. (1998) (5)
117 : Meta-Analysis of Amifostine in Radiotherapy (MAART): Preliminary Analysis of 11 Randomized Clinical Trials Including 1,014 Patients (2006) (5)
Clinical, dosimetric, and radiographic correlation of radiation injury involving the brainstem and the medial temporal lobes following stereotactic radiotherapy for neoplasms of central skull base (2010) (5)
109 : Sociodemographic Factors Are Significant Predictors of Toxicity in RTOG Non-Operative NSCLC Trials (2006) (5)
Retroperitoneal Metastasis Abutting Small Bowel: A Novel Magnetic Resonance-Guided Radiation Approach (2018) (5)
A Deep Dive into Understanding Tumor Foci Classification using Multiparametric MRI Based on Convolutional Neural Network (2019) (5)
Impact of sociodemographic factors on the radiotherapeutic management of lung cancer: Results of a Quality Research in Radiation Oncology survey. (2014) (4)
Detection of Dominant Intraprostatic Lesions in Patients With Prostate Cancer Using an Artificial Neural Network and MR Multimodal Radiomics Analysis (2017) (4)
"Examinations in Radiation Oncology: Listening, Learning, and Looking Forward Together". (2019) (4)
Radiation Therapy in Elderly Persons: An Old Issue With New Approaches. (2017) (4)
Reply to M.J. Brenner et al and I.R. Vogelius et al. (2014) (4)
Dosimetric impact of angular deviations in positioning for spinal radiosurgery. (2009) (4)
Thoracic radiotherapy for limited stage small cell lung carcinoma. (2012) (4)
Charlson Comorbidity score influence on prostate cancer survival and radiation-related toxicity. (2020) (4)
American Radium Society (ARS) and American College of Radiology (ACR) Appropriate Use Criteria Systematic Review and Guidelines on Reirradiation for Non-small Cell Lung Cancer (NSCLC) (2020) (4)
The potential of iodine for improving breast cancer diagnosis and treatment. (2013) (4)
Correlation of hypoxic prostate/muscle pO2 (P/M PO2) ratio and biochemical failure in patients with localized prostate cancer: Long-term results. (2016) (4)
69 A randomized phase III study of accelerated hyperfractionation versus standard fractionation in patients with unresected brain metastasis: A report of radiation therapy oncology group (RTOG) 9104 (1996) (4)
SU‐FF‐T‐60: A Simplified Frame Work Using Deep Inspiration Breath‐Hold (DIBH) for the Treatment of Left Breast Cancer with Improved Heart Sparing (2006) (4)
184 Induction paclitaxel-carboplatin followed by concurrent radiotherapy & dose escalation of paclitaxel-carboplatin in unresectable, locally advanced non-small cell lung CA: Report of FCCC 94-001 (1999) (4)
Quality of Life Implications of Dose-Escalated External Beam Radiation for Localized Prostate Cancer: Results of a Prospective Randomized Phase 3 Clinical Trial, NRG/RTOG 0126 (2022) (4)
Patterns of care survey (PCS) in locally advanced non-small cell lung cancer (LA-NSCLC) and limited small cell lung cancer (LD-SCLC): how well does current practice follow the literature? (2003) (4)
Surgical Patterns of Care in Operable Lung Carcinoma Treated with Radiation (2006) (4)
Prostate Localization: Fiducial Marker Versus Cone Beam CT (CBCT) 3D Image Fusion (2007) (4)
Single Isocenter Lung SBRT for Multiple PTV Lesions (2014) (4)
Role of prostate dose escalation in patients with >15% risk of pelvic lymph-node involvement (2003) (4)
Hypoxia in Human Prostate Carcinoma (2001) (3)
Characterization of insulinase from mammalian and non-mammalian livers. (1984) (3)
Translational Research Program (2001) (3)
Rethinking prognostic factors in the era of combined modality therapy for Locally Advanced Non-small Cell Lung Cancer (LA-NSCLC): a retrospective analysis of RTOG Protocols 9410 and 9801: A1-03 (2007) (3)
Randomized chemoradiation for patients with locally advanced inoperable non-small cell lung cancer (NSCLC): Long-term follow-up of RTOG 92-04 (2000) (3)
Degradation of the 34 amino acid gastrin by rat tissue homogenates. (1985) (3)
Phase I Dose Escalation Trial of Image Guided Stereotactic Body Radiotherapy for Lung Tumors (2008) (3)
Radiotherapy patterns of care study in lung cancer: Analysis of surgical cohort (2004) (3)
QRRO: Estimating National Benchmarks for Quality Indicators for Non–small Cell Lung Cancer (NSCLC) (2009) (3)
RTOG 0118: A phase III study of conventional radiation therapy alone vs. conventional radiation therapy plus thalidomide for multiple brain metastases (2005) (3)
An Analysis of Clinical Toxic Effects and Quality of Life as a Function of Radiation Dose and Volume After Lung Stereotactic Body Radiation Therapy (2021) (3)
Association Between Physician and Patient Reported Symptoms in Patients Treated with Definitive Radiotherapy for Locally Advanced Lung Cancer in a Statewide Consortium. (2021) (3)
A review of palliative radiotherapy for lung cancer and lung metastases (2012) (3)
The Biological Process of Aging and the Impact of Ionizing Radiation. (2022) (3)
Is Stereotactic Body Radiotherapy (SBRT) Safe for Central Non-small Cell Lung Cancer (NSCLC) Lesions? (2008) (3)
Will future progress in non-small-cell lung cancer be step by step... or by leaps and bounds? (2005) (3)
Routine use of MRI and CT simulation for treatment planning of intensity modulated radiation therapy (IMRT) in prostate cancer (2001) (3)
346 Cisplatin (P), ifosfamide (I), prolonged oral etoposide (E), and concurrent accelerated hyperfractionated thoracic radiotherapy (TRT) for patients with limited small cell lung cancer (LSCLC): Preliminary results of a phase II trial (1997) (3)
Marking hypoxia in rat prostate carcinomas with beta-D-[125I]azomycin galactopyranoside and. (2001) (3)
Optimum beam angles for the conformal treatment of lung cancer: A CT simulation study (2000) (3)
NCOG-01. NEUROCOGNITIVE FUNCTION (NCF) AND QUALITY OF LIFE (QOL) RESULTS FROM A PHASE II STUDY OF TEMOZOLOMIDE-BASED CHEMORADIOTHERAPY REGIMEN FOR HIGH RISK LOW-GRADE GLIOMAS (2019) (3)
Automatic segmentation of the prostate gland on planning ct images using deep neural networks (DNN). (2018) (3)
Monte carlo verification of MR-based treatment planning for intensity modulated radiation therapy (2002) (3)
P2.12-20 NRG Oncology/Alliance LU005: A Phase II/III Randomized Study of Chemoradiation Versus Chemoradiation Plus Atezolizumab in LS-SCLC (2019) (3)
Increasing hypoxia correlates with increased expression of the angiogenesis marker, VEGF in human prostate carcinoma (2000) (3)
An uncertainty-aware deep learning architecture with outlier mitigation for prostate gland segmentation in radiotherapy treatment planning. (2022) (2)
P-178 Tumor cell viability following radiofrequency ablation of resectable primary lung cancer: Initial results from an ablate and resect study (2003) (2)
TH‐C‐303A‐08: Prostate Localization Using Daily Cone‐Beam Computed Tomography Imaging: Assessment of Accuracy Using Similarity Metrics and Observation‐Based Measures (2009) (2)
Effect of inhomogeneities in small fields: Dosimetric implications for complex IMRT of lung (2000) (2)
Dose-volume histogram analysis does not completely predict the incidence of late effects of radiation in prostate cancer (2004) (2)
SU‐EE‐A2‐04: Verification of the Rotational Accuracy of the Brainlab Robotics 6D Couch and the ExacTrac X‐Ray 6D Fusion System (2008) (2)
Image-Guided Radiation Therapy for Lung Cancer (2013) (2)
The Influence of Gender, Race, and Marital Status on Survival in Lung Cancer Patients: Meta-analysis of Radiation Therapy Oncology Group (RTOG) Trials (2009) (2)
Non – small-cell lung cancer , mesothelioma , and thymoma (2003) (2)
Effect of dose prescription on HDR vaginal brachytherapy (2006) (2)
Randomized Prospective Trial of Stereotactic Radiosurgery versus Chemotherapy for Recurrent Malignant Glioma After Second-line Chemotherapy (2019) (2)
Small-Cell Lung Cancer, Mesothelioma, and Thymoma (2015) (2)
Prognostic Biomarkers in Non-Small Cell Lung Cancer Patients Treated With Radiation Therapy (2014) (2)
A Simplified Framework for the Treatment of Left Breast Cancer Using Deep Inspiration Breath Hold (DIBH) With Reduced Heart Dose (2007) (2)
Phase I dose-escalation study of thoracic irradiation with concurrent chemotherapy for patients with limited small cell lung cancer (LSCLC). Radiation therapy oncology group RTOG (2003) (2)
Gene therapy for prostate cancer. (2003) (2)
PET response following stereotactic body radiotherapy for non-small cell lung carcinoma correlates with local control (2007) (2)
Uptake of Adjuvant Durvalumab After Definitive Concurrent Chemoradiotherapy for Stage III Nonsmall-cell Lung Cancer (2022) (2)
Clinical Outcome Assessments Toolbox for Radiopharmaceuticals (2019) (2)
Radiation Therapy Oncology Group. Research Plan 2002-2006. Outcomes Committee. (2001) (2)
Can physicians accurately predict survival time in patients with metastatic cancer? Analysis of RTOG 9714 (2004) (2)
TH-D-VaIB-02: Skin and Body Dose Measurements for Varian Cone-Beam CT (CBCT) During IMRT for Prostate Cancer (2006) (2)
The effect of smoking on survival of prostate cancer patients treated with radiation therapy (2004) (2)
A phase I radiation dose escalation of stereotactic body radiotherapy for malignant lung tumors (2010) (2)
Factors Associated with Patterns of Practice for Elective Nodal Irradiation in Non-small Cell Lung Cancer Patients among US Radiation Oncologists (2009) (2)
Electronic Web-based Technology Significantly Improves Quality of Life (QOL) Data Collection: Analysis of RTOG 0828 (2011) (2)
Socio-demographic variables influence outcome in Radiation Therapy Oncology Group head and neck trials. (2004) (2)
SU‐FF‐T‐394: An Image Guided Target Localization System for Brain Radiosurgery and Fractionated Stereotactic Radiotherapy Using a Non‐Invasive Fixation (2005) (2)
Radiation Therapy in Older Adults With Cancer: A Critical Modality in Geriatric Oncology. (2022) (2)
A Comparative Study for Daily Localization with 3D Ultrasound, Cone Beam CT, and Implanted Prostate Fiducial Markers for Patients undergoing IGRT for Prostate Cancer (2009) (2)
Radiosurgery Alone or Postoperative Radiosurgery for 1-3 Brain Metastases (2008) (2)
WE‐C‐BRC‐08: A Method to Evaluate Region‐Specific Pulmonary Function Using 4D CT Images for Lung Cancer Patients Undergoing Radiation Therapy (2009) (2)
Who enrolls onto clinical oncology trials? a patterns of care study analysis (2003) (2)
A pooled analysis of concurrent chemoradiotherapy (CCRT) for patients with stage III non-small cell lung cancer (NSCLC) who participated in U.S. Cooperative Group Trials: comparing the outcomes of elderly to younger patients (pts) (2016) (2)
MR-based Automatic Air Segmentation for Generation of Synthetic CTs in the Head Region (2015) (2)
SU-C-210-01: Are Clinically Relevant Dosimetric Endpoints Significantly Better with Gating of Lung SBRT Vs. ITV-Based Treatment?: Results of a Large Cohort Investigation Analyzing Predictive Dosimetric Indicators as a Function of Tumor Volume and Motion Amplitude (2015) (2)
Can Patient Reporting Affect Radiation Pneumonitis (2008) (2)
Radiomics outperforms clinical factors in characterizing human papilloma virus (HPV) for patients with oropharyngeal squamous cell carcinomas (2021) (2)
Treatment, patient and tumor characteristics impact quality of life (QOL) in patients with locally advanced head and neck cancer: Report of the radiation therapy oncology group (RTOG) trial 90-03 (2001) (2)
Atlas of Genitourinary Oncology (2002) (2)
Breast cancer patients have better outcomes than prostate cancer patients for palliation of painful bone metastases: Results of RTOG 97–14 (2005) (1)
SBRT for Adrenal Gland Metastasis using Single Dose vs. Fractionated Dose Regimen (2010) (1)
2743 : Dose Delivered From Daily CBCT to Patients Receiving RT for H/N And Prostate Cancer (2006) (1)
SU‐FF‐J‐01: Feasibility of a Pre‐Object‐Grid to Reduce Scatter and Improve Image Quality in Cone‐Beam Computed Tomography (CBCT) (2009) (1)
INDUCTION AND ADJUVANT THERAPY FOR N2 NON-SMALL-CELL LUNG CANCER (2013) (1)
How does CBCT reconstruction algorithm impact on deformably mapped targets and accumulated dose distributions? (2021) (1)
Health-Related Quality of Life and Cognitive Status in Patients with Glioblastoma Multiforme Receiving Escalating Doses of Conformal Three-Dimensional Radiation on RTOG 9803 (2005) (1)
Lung Cancer (2019) (1)
Controversies in Lung Cancer: A Multidisciplinary Approach (2001) (1)
Patterns of practice in radiation therapy for non-small cell lung cancer among members of American Society of Therapeutic Radiology and Oncology (2007) (1)
NRG Oncology/Alliance LU005: A Phase II/III Randomized Study of Chemoradiation vs. Chemoradiation Plus Atezolizumab in Limited Stage Small Cell Lung Cancer. (2021) (1)
Technical Note: On the development of an outcome-driven frequency filter for improving Radiomics-based modeling of Human Papilloma Virus (HPV) in patients with oropharyngeal squamous cell carcinomas. (2021) (1)
Association between Adverse Events and Quality of Life in Patients Treated with Radiotherapy for Locally Advanced Non-Small Cell Lung Cancer (2019) (1)
Automated segmented field selection for IMRT using utility based decision theory (1998) (1)
SU‐FF‐J‐112: Accurate Targeting Breast Cancer in Real‐Time Stereovision‐Guided Radiotherapy (2007) (1)
SU-E-T-289: Dose-Volume-Effect Relationships for Lung Cancer Patients Treated with SBRT On a Prospective Protocol (2015) (1)
SU‐FF‐T‐186: Commissioning of Tissue Inhomogeneity Correction of Eclipse Radiation Treatment Planning System Using a Lung Phantom (2005) (1)
NRG Oncology/RTOG 0415, Hypofractionation in Patients with Low-Risk Prostate Cancer: Are Patient Reported Outcomes the Practice Change Tipping Point? (2017) (1)
Region-based Correction of Deformable Image Registration Errors for Adaptive Radiation Therapy (2012) (1)
Phase 2 trial of cisplatin (C), etoposide (E), and radiation (RT) followed by gemcitabine (G) vs G and docetaxel (D) in stage III A/B unresectable non-small-cell lung cancer (NSCLC): P2-195 (2007) (1)
Radiomics analysis of contrast-enhanced ct images for detection of human papilloma virus in patients with oropharyngeal cancers. (2018) (1)
Radiation Therapy Oncology Group. Research Plan 2002-2006. Lung Cancer Committee. (2001) (1)
Back to B.E.D. Predictors of Outcome in RTOG Non-Operative Non-Small Cell Lung Cancer (NSCLC) Trials (2005) (1)
Palliative Radiotherapy in Advanced Lung Cancer (2013) (1)
MO-F-CAMPUS-T-04: Development and Evaluation of a Knowledge-Based Model for Treatment Planning of Lung Cancer Patients Using Stereotactic Body Radiotherapy (SBRT) (2015) (1)
2034 : Pilot Study of a Real-Time Stereovision-Based Image-Guided Radiotherapy for Breast Cancer (2006) (1)
In reply to Hastings and Iganej. (2012) (1)
Salvage Radiosurgery of Recurrent Glioblastoma Multiforme: Radiographic Tumor Control and Clinical Outcome (2007) (1)
Recommendations for dose calculations of lung cancer treatment plans treated with stereotactic ablative body radiotherapy (SABR) (2014) (1)
What are the Factors Affecting Patient Positioning Accuracy After Image Fusion Guided Target Localization in Stereotactic Body Radiosurgery (2007) (1)
2197 A phase III study evaluating the efficacy of conventional radiation therapy with or without recombinant β-interferon for patients with locally advanced non-small cell lung cancer and poor prognostic characteristics (RTOG 93-04) (1999) (1)
Assessment of 2D X-ray and Volumetric-based Localization Imaging for Patients Treated with SRS and SBRT (2009) (1)
Analysis of CBCT-based image guidance for a large cohort of lung cancer patients treated with SABR (2015) (1)
EXTERNAL BEAM RADIATION THERAPY TREATMENT PLANNING FOR CLINICALLY LOCALIZED PROSTATE CANCER on Radiation Oncology–Prostate: (2013) (1)
Prognostic significance of QOL deterioration during early lung cancer survivorship: Secondary analysis of RTOG 0212 and 0214. (2011) (1)
MRI-guided Radiotherapy (MRgRT) for treatment of Oligometastases: Review of clinical applications and challenges. (2022) (1)
Quality Adjusted Survival Comparing Standard Versus Hypofractionated Radiation Therapy in the Treatment of Prostate Cancer (2015) (1)
Quality of Survivorship Among Patients With Locally Advanced NSCLC Treated With Chemoradiation on RTOG 0617 (2017) (1)
WE-E-BRB-03: Development of a Deformable Dosimetric Phantom for Verification of 4D Dose Calculation Algorithms. (2012) (1)
A novel method of boron delivery using sodium iodide symporter for boron neutron capture therapy. (2010) (1)
Phase II trial of cisplatin (C), etoposide (E) and radiation (RT) followed by gemcitabine (G) vs G and docetaxel (D) in stage III A/B unresectable non-small cell lung cancer (NSCLC) (2006) (1)
Initial Clinical Experience With an Open High-Field 1.0T MR-SIM (2014) (1)
Intrafraction Variability and Deformation Quantification for Accelerated Partial-Breast Irradiation (APBI) (2013) (1)
Radiation Therapy Oncology Group. Research Plan 2002-2006. Translational Research Program. (2001) (1)
1127: Socio-Demographic Predictors of Biochemical Failure and Survival Among High Risk Patients Treated on Radiation Therapy Oncology Group (RTOG) Prostate Cancer Trials: A Meta-Analysis (2006) (1)
Quality of Life (QOL) Supercedes the Classic Predictors of Survival in Locally Advanced Non-Small Cell Lung Cancer (NSCLC): An Analysis of Radiation Therapy Oncology Group (RTOG) 9801 (2007) (1)
514. Clinical Trials of Oncolytic Adenovirus-Mediated Gene Therapy (2016) (1)
An audiological analysis of stereotactic radiation strategies to preserve hearing in patients with vestibular schwannomas. (2014) (1)
A Pilot Study on the Feasibility of MRI Simulation in Radiation Therapy Using an Open-Platform MR Scanner (2011) (1)
SU‐E‐J‐21: Verification of a Monte Carlo Model of CBCT Flat Panel Detector Using BEAMnrc/EGSnrc Code (2011) (1)
1023 : Automatic and Accurate Prostate Localization on Daily CBCT Images Using Intensity-Based 3D/3D Image Registration (2006) (1)
Effect of education and standardization of cardiac dose constraints on heart dose in lung cancer patients receiving definitive radiation therapy across a statewide consortium. (2022) (1)
Decline in Tested and Patient-reported Cognitive Functioning Following Prophylactic Cranial Irradiation for Lung Cancer: Secondary Analysis of RTOG 0212 and 0214 (2011) (1)
SU‐FF‐J‐39: Image Guided Radiation Therapy: Investigation of Interfraction Setup and External Contour Variation for Prostate IMRT Using CT and MRI (2005) (1)
SU-FF-J-80: Clinical Procedures for Daily Patient Setup Verification Using On-Board Imager (OBI) (2005) (1)
SU-D-204-07: Retrospective Correlation of Dose Accuracy with Regions of Local Failure for Early Stage Lung Cancer Patients Treated with Stereotactic Body Radiotherapy. (2016) (1)
PHASE II STUDY OF POSTOPERATIVE ADJUVANT IMMUNOTHERAPY AND RADIATION IN PATIENTS WITH COMPLETELY RESECTED STAGE II AND STAGE IIIA NON-SMALL CELL LUNG CANCER (2005) (1)
115 Dose escalation with 3-D CRT in prostate cancer: Five year dose responses and optimal treatment (1997) (1)
Comparisons of Six Similarity Measure Functions for Intensity-based 3D/2D Image Fusion (2005) (1)
MO‐E‐330A‐06: Cone Beam CT (CBCT) Image Fusion for Prostate Localization: Interobserver Variability Study Using Manual and Automatic Registration (2006) (1)
Dancing prostates: measurement of intra-fractional prostate motion using MRI (2001) (1)
P48.02 NRG Oncology/Alliance LU005: Chemoradiation vs. Chemoradiation Plus Atezolizumab in Limited Stage Small Cell Lung Cancer (2021) (1)
Bowel and Bladder Function of Men on a Phase 3 Randomized Study of High Versus Standard Dose of 3D-CRT/IMRT in Patients Treated for Localized Prostate Cancer (2015) (1)
MO‐E‐330A‐06: Cone Beam CT (CBCT) Image Fusion for Prostate Localization: Interobserver Variability Study Using Manual and Automatic Registration (2006) (1)
Accumulated Dose Estimation in Lung Stereotactic Body Radiation Therapy using Deformable Image Registration Algorithm (2017) (1)
Liver Stereotactic Body Radiation Therapy Using Real Time Magnetic Resonance Guidance (2019) (1)
SU-EE-A2-06: An Integrated Software Platform for Treatment Documentation and Outcome Analysis for Stereotactic Radiosurgery and Hypo-Fractionated Stereotactic Body Radiotherapy (2008) (1)
Magnetic Resonance Guided Linear Accelerator for Stereotactic Radiosurgery Treatment (2018) (1)
Development of 3D printed immobilization for the MR-linac: Toward high precision brain treatments (2018) (1)
SU‐FF‐J‐79: Implementation of Four Different Image‐Guided Radiotherapy (IGRT) Systems in a Radiotherapy Department (2006) (1)
Veterans Affairs Radiation Oncology Quality Surveillance Program and American Society for Radiation Oncology Quality Measures Initiative. (2022) (1)
Gold Nanoparticles as Radiosensitizers in MDA MB 231 Xenograft Mouse Model (2019) (1)
POSTOPERATIVE ADJUVANT THERAPY IN NON-SMALL-CELL LUNG CANCER (2010) (1)
2145 Oral sucralfate reduces the late GI effects of conformal RT for prostate CA: A double-blind placebo-controlled randomized trial (1999) (1)
Dose Escalated Radiotherapy (RT) Alone or in Combination With Short-Term Total Androgen Suppression (TAS) for Intermediate Risk Prostate Cancer: Patient Reported Outcomes (PROs) From the NRG Oncology/RTOG 0815 Randomized Trial. (2021) (1)
A Phase 1b/2a Study Evaluating the Pharmacokinetics, Safety, and Efficacy of Nano-Genistein and Chemoradiotherapy for Non-Small Cell Lung Cancer (2018) (1)
In reply [6] (2005) (1)
Risk factors for late bowel and bladder toxicities in NRG Oncology prostate cancer trials of high-risk patients: A meta-analysis of physician-rated toxicities (2018) (1)
Improved target coverage and rectal sparing for treatment of prostate cancer using IMRT vs 3D CRT (2002) (1)
2256 : Daily Pre-Treatment Cone Beam CT-Scans (CBCT) During IMRT for Prostate Cancer (PC): On-Line Evaluation of Prostate Displacement and Deformation (PDD) due to Rectal Filling (RF) and its Correction (2006) (1)
Quantifying injury to the brain from radiation therapy (RT) with whole brain N-acetylaspartate (WBNAA) proton magnetic resonance spectroscopy (1H-MRS) (2000) (0)
An equilibrium model for characterization and classification of dominant intraprostatic lesions and normal tissues in patients with prostate cancer. (2017) (0)
SU‐FF‐T‐364: Quality Assurance (QA) Procedure for KV‐KV Setup Correction Verification Using Autodetection of Radiopaque Markers (2007) (0)
SU-E-T-487: Spatial Assessment of Dose Distributions for Patients with Lung Cancer Treated with Stereotactic Ablative Radiotherapy (SABR). (2012) (0)
Deformable image registration for geometrical evaluation of DIBH radiotherapy treatment of lung cancer patients (2014) (0)
Accurate Prostate Lesion Classification Using Convolutional Neural Network and Weighted Extreme Learning Machine (2019) (0)
Randomized Phase III, Double Blind, Placebo-Controlled Study of Prophylactic Gabapentin for the Reduction of Oral Mucositis Pain During the Treatment of Oropharyngeal Squamous Cell Carcinoma (2022) (0)
Prostate cancer malignancy detection and localization from mpMRI using auto-deep learning as one step closer to clinical utilization (2022) (0)
Oncolytic virus-based suicide gene therapy for cancer treatment: a perspective of the clinical trials conducted at Henry Ford Health (2023) (0)
Magnetic resonance imaging‐only‐based radiation treatment planning for simultaneous integrated boost of multiparametric magnetic resonance imaging‐defined dominant intraprostatic lesions (2022) (0)
SU-E-J-59: Dual Imaging Guided Localization System for Spine Radiosurgery. (2012) (0)
Partial Volume Tolerance of Human Spinal Cord to Single Dose Radiosurgery: Accumulated Experience of 211 Procedures (2005) (0)
Recent advances and dilemmas in the radiotherapeutic management of locally advanced non-small cell lung cancer. (2003) (0)
TH-A-BRF-08: Deformable Registration of MRI and CT Images for MRI-Guided Radiation Therapy. (2014) (0)
Deep Radiomics Feature Analysis for HPV-Based Stratification of Patients with Oropharyngeal Cancer Using Kohonen Self-Organizing-Map Technique (2019) (0)
Consensus Quality Measures and Dose Constraints for Lung Cancer from the Veterans Affairs Radiation Oncology Quality Surveillance Program and American Society for Radiation Oncology (ASTRO) Expert Panel. (2023) (0)
SU‐E‐T‐651: Radiobiological Effect of Target Volume in SBRT of Lung Tumor: Comparison of Treatment Planning Algorithms Between Pencil Beam Algorithm and Monte Carlo Method (2011) (0)
A Physiologically Nested Pharmacokinetic Model in Dynamic Contrast-Enhanced Magnetic Resonance Imaging for Detection of Dominant Intraprostatic Lesions in Patients With Prostate Cancer (2016) (0)
SU‐FF‐T‐322: On Optimization of Treatment Planning for Intensity Modulated Spinal Radiosurgery (2007) (0)
In reply to Cheung. (2013) (0)
SU‐FF‐T‐401: The Beam Performance and Dose Distribution of a Needle‐Based Miniature X‐Ray Generating System for Medical Application (2007) (0)
Predictors of Pneumonitis after Lung Cancer Radiotherapy (2020) (0)
Prospective Evaluation of Limited Stage Small Cell Lung Cancer (LS-SCLC) Fractionation Regimen Usage and Toxicity in a Large Statewide Quality Collaborative (2022) (0)
WE-AB-207B-05: Correlation of Normal Lung Density Changes with Dose After Stereotactic Body Radiotherapy (SBRT) for Early Stage Lung Cancer. (2016) (0)
Can We Accurately Accumulate Dose to Regressing Tumors for Adaptive Treatment of Patients With Lung Cancer (2015) (0)
Can Physics Consults Improve Patient-Centered Care in Radiation Oncology? (2023) (0)
Further Thoughts on a Rare Entity (2006) (0)
SU‐E‐I‐26: A Monte Carlo Based Study on X‐Ray Characteristics of Two Commercial Multi‐Detector CT Simulators (2011) (0)
WE-E-141-09: FMEA and Fault Tree Ananlysis Applied to Vendor Customer Technical Bulletins. (2013) (0)
SU‐FF‐T‐391: Study of Treatment Couch Leveling and Sagging Related to Patient Weight and Couch Longitudinal Positions (2007) (0)
Predictors of Heart Dose From Lung Radiation Therapy in a Large Consortium of Community and Academic Practices (2016) (0)
Real time patient‐reported outcome measures in patients with cancer: Early experience within an integrated health system (2023) (0)
TH-E-BRC-11: Practical Methods for Improving Dose Non-Uniformity in Monte Carlo- Based IMRT Planning of Lung Tumors Treated with Stereotactic Body Radiotherapy (SBRT) (2011) (0)
SU‐FF‐J‐76: Inter‐Fractional Prostate Motion Measured with 3D Daily Ultrasound Images (2007) (0)
Lung cancer committee (2001) (0)
ACR Appropriateness Criteria s Postoperative Adjuvant Therapy in Non-Small Cell Lung Cancer (2014) (0)
Abstract 555: Examination and evaluation of MR radiomics features for characterization of dominant intraprostatic lesions (2017) (0)
GENIS: Gene Expression of Sodium Iodide Symporter for Noninvasive Imaging of Gene Therapy (GT) in Human Prostate Carcinoma (2007) (0)
119 : Predictors of Late Toxicities and Symptom Clusters in Radiation Therapy Oncology Group (RTOG) Prostate Cancer Trials of High Risk Patients: A Meta-Analysis of Physician Rated Toxicities (2006) (0)
Does Marital Status Influence Survival among Women with Invasive Cervical Cancer? Analysis of Population-based Surveillance, Epidemiology and End Results (SEER) Data (2008) (0)
Quality of life (QOL) variables influence local regional control in radiation therapy oncology group (RTOG) headsneck trials (9003 and 9111) (2004) (0)
2092 Is it necessary to irradiate the entire seminal vesicles in patients at risk for seminal vesicle invasion (1997) (0)
Abstract 4539: Examination of zone-based radiomic features for characterization of dominant intraprostatic lesions using MR multi-modal information (2018) (0)
Racial Differences in Treatments and Toxicity in Patients With Non–Small-Cell Lung Cancer Treated With Thoracic Radiation Therapy (2022) (0)
Evaluating organ delineation, dose calculation and daily localization in an open-MRI simulation workflow for prostate cancer patients (2015) (0)
Which Formula Best Predicts Disease-Free Interval in Localized Prostate Cancer? (1997) (0)
Effect of Education and Standardization of Cardiac Dose Constraints on Heart Dose in Lung Cancer Patients Receiving Definitive Radiation Therapy Across a Statewide Consortium. (2021) (0)
Prediction of Response to Radiation Therapy Treatment of Head and Neck Cancers Using an Artificial Neural Network Developed From Cone Beam Computed Tomography Image Textural Information (2016) (0)
How does cbct image quality impact on adaptive, accumulated dose distributions? (2018) (0)
RTOG/NRG 1115 Quality of Life of Phase III Dose Escalated Radiation Therapy (RT) and Standard Androgen Deprivation Therapy (ADT) with GnRH Agonist vs. Dose Escalated RT and ADT with GnRH Agonist and Orteronel (TAK-700) for Men with High-Risk Prostate (2022) (0)
Abstract CT196: A phase I clinical trial of oncolytic adenovirus mediated suicide and interleukin-12 gene therapy in patients with recurrent prostate cancer (2023) (0)
Inter-fraction Cardiac Substructure Displacement Assessed via Magnetic Resonance-guided Radiation Therapy (2019) (0)
Gating evaluation of an MRGRT system using a novel MR-compatible motion phantom. (2018) (0)
Glioblastoma MR Images Synthesis with Generative Adversarial Network (2020) (0)
Impact of Intensity Modulated Radiation Therapy on Acute Toxicity in Locally Advanced Lung Cancer: Results of a Large Statewide Multi-center Cohort (2018) (0)
2784 : Quantification of Prostate Motion Based on 3D/3D Image Registration Using Daily Cone Beam CT (CBCT) (2006) (0)
An Unsupervised Autoencoder Developed from Dynamic Contrast-Enhanced (DCE)-MRI Datasets for Classification of Acute Tumor Response in an Animal Model (2022) (0)
MO‐E‐BRA‐05: Clinical Issues Associated with the Use of Monte Carlo‐Based Prospective Planning for Lung SBRT and Spine SRS Patients (2010) (0)
Report of Quality Research in Radiation Oncology (QRRO) Survey for Lung Cancer Patients Treated in the USA between 2006 and 2007 (2010) (0)
A TCP Model Incorporating Spatial Variation in Tumor Cell Density and Setup Uncertainty to Guide Treatment Planning (2010) (0)
TU‐C‐204B‐01: Reduce Patient Dose and Improve Image Quality in CBCT for Image Guided Radiotherapy (2010) (0)
SU‐E‐J‐78: Initial Experience with MR Simulation in Radiation Therapy Using An Open‐Platform MR Scanner: Considerations for Routine Clinical Use (2011) (0)
Characterization of Local Spatial Information Utilized in Training of Deep Convolutional Neural Networks (DCNN) for Automatic Segmentation of the Prostate on CT Images (2019) (0)
TH-C-141-11: Evaluation of MR Images as the Planning and Reference Dataset for Daily CBCT-Based IGRT of the Prostate. (2013) (0)
2597 : Pretreatment Quality of Life in a Prospective Lung Cancer Trial: Should Gender Differences Be Stratified by Performance Status? (2006) (0)
Assessment of Differences in Academic Rank and Salary by Gender and Race Among United States Academic Radiation Oncologists. (2021) (0)
Hormones in addition to radiation for localized prostate cancer: How much and for whom? (2008) (0)
Evaluation of gantry speed on image quality and imaging dose for 4D cone-beam CT acquisition (2016) (0)
Influence of Pixel Size on Target Delineation and Treatment Planning for Stereotactic Radiosurgery (2010) (0)
SU-GG-I-102: Evaluation of Nine Similarity Metrics for Intensity-Based CT-To-CBCT Prostate Registrations (2008) (0)
SU‐FF‐T‐61: A Pseudo‐Tangential IMRT Technique for the Whole Large Left Breast Radiation Therapy Using Helios/Eclipse System (2005) (0)
1010 Post treatment PSA nadirs support continuing dose escalation study in patients with pretreatment PSA levels >10 ng/ml, but not in those with PSA <10 ng/ml (1996) (0)
The Impact of Marital Status and Race in Patients Enrolled in Radiation Oncology Group (RTOG) Prostate Cancer Trials (2009) (0)
ACR Appropriateness Criteria s Radiation Therapy for Small-Cell Lung Cancer (2014) (0)
1504 RANDOMIZED, CONTROLLED, PHASE 2 TRIAL OF ONCOLYTIC ADENOVIRUS-MEDIATED SUICIDE GENE THERAPY PLUS IMRT VERSUS IMRT ALONE IN NEWLY DIAGNOSED, INTERMEDIATE-RISK PROSTATE CANCER (2013) (0)
Post-Treatment PSA Nadir as an Independent Predictor of Distant Metastasis Following Radiotherapy for Prostate Cancer: 10:29 AM (29) (2002) (0)
WE‐E‐AUD C‐06: 4D Imaging of Lung Cancer Patients Treated with Stereotactic Body Radiotherapy (SBRT): Assessment of Target Volumes (2008) (0)
SU‐FF‐I‐94: Intensity‐Based 3D/3D Image Registration for Prostate Localization On CBCT Images (2006) (0)
Gerald E. Hanks, MD, FASTRO. (2018) (0)
Quantifying the Dosimetric Impact of a Novel Synthetic CT Algorithm for MR Simulation of Prostate Cancer Radiation Therapy (2015) (0)
Predictors of Early Death or Hospice in Curative Inoperable Lung Cancer Patients (2020) (0)
Molecular targets that sensitize cancer to radiation killing: From the bench to the bedside. (2022) (0)
Evaluation of the Systematic Accuracy of Cutting Edge Technology for Stereotactic Radiosurgery Treatment (2014) (0)
Human Radiation Injury (2011) (0)
Geometric and radiation characterization of a new double stack multileaf collimator in a low field MR-Linac. (2018) (0)
SU‐FF‐T‐43: A Simplified Framework for CT Simulation of Left Breast Patients Using Deep Inspiration Breath‐Hold (DIBH) (2007) (0)
Evaluation of Practice Patterns and Outcomes after Implementing SMART for Pancreatic Cancer (2022) (0)
LETTER: Correction: Prophylactic Cranial Irradiation for NSCLC (2/10/10 issue) (2010) (0)
Predictors on Longitudinal Changes of Clinician Reported Symptom Clusters Identified in Patients with Head and Neck Cancer Treated on RTOG Trials (2011) (0)
ACR Appropriateness Criteria s Induction and Adjuvant Therapy for N2 Non–small-cell Lung Cancer (2015) (0)
Predictors of Toxicity Among Older Adults with Cancer. (2022) (0)
SU‐FF‐I‐93: Comparison of Seven Similarity Measures for Intensity‐Based 3D/3D Image Registrations On CBCT (2006) (0)
P-724 4D-CT and PET based treatment planning for fractionatedstereotactic lung radiosurgery (2005) (0)
The impact of Charlson Comorbidity Index on survival outcomes in men with prostate cancer who underwent definitive prostate radiotherapy. (2019) (0)
Changing Practice Patterns in the Radiation Treatment Delivery for Locally Advanced Lung Cancer: Results from a Statewide Consortium (2019) (0)
How Does CBCT Image Quality Impact on Deformably Mapped Targets and Accumulated Dose Distributions? (2019) (0)
Surgical Resection Plus Radiosurgery Only to the Resection Cavity for Solitary Brain Metastasis: Ten-year Experience (2009) (0)
SU-E-T-197: A Comprehensive Variance Reporting System and an Analysis of Variances Reported at Our Institution. (2012) (0)
MR Guided Stereotactic Body Radiation Therapy with Simultaneous Integrated Boost to Dominant Intraprostatic Lesions for Prostate Cancer: A Retrospective Dosimetric Study (2019) (0)
1044 : Accelerated Radiation Therapy Using Altered Fractionation Combined With Chemotherapy in Stage III Inoperable Non-Small-Cell Lung Cancer: An Analysis of Two Prospective Phase II Trials (2006) (0)
Prognostic Biomarkers in Non-Small Cell Lung Cancer Patients Treated With Radiation Therapy: Locally Advanced Non-Small Cell Lung Cancer (2014) (0)
Radiomic Analysis of Primary GTV and CTV for Prediction of Extranodal Extension Using Diagnostic CT Images in Patients With Oropharyngeal Squamous Cell Carcinoma. (2021) (0)
Particle Therapy in All Its Parts (2009) (0)
OC-0546: Minimally ablative dose (MAD) for the treatment of lung cancer using SBRT: Is it such a “MAD” concept? (2013) (0)
Gold Nanoparticle (AuNP) as a Therapeutic Enhancer for Radio – And Immunotherapy Therapy Combination in Triple Negative Breast Cancer (2022) (0)
TU‐C‐213CD‐09: Dosimetric Impact of the Interplay Effect on RapidArc versus IMRT Delivery of Lung Cancer Treatment Using SBRT (2012) (0)
10 A PHASE III COMPARISON OF PROPHYLACTIC CRANIAL IRRADIATION (PCI) VERSUS OBSERVATION IN PATIENTS WITH LOCALLY ADVANCED NON-SMALL CELL LUNG CANCER (LANSCLC). INITIAL RESULTS OF NCIC BR.C1/RTOG 0214 (2009) (0)
Correlation of Normal Lung Density Changes With Dose After Stereotactic Body Radiation Therapy for Early Stage Lung Cancer (2017) (0)
2719 : Evaluation of Incidental Dose To the Clinical Target Volume (CTV) In Hypofractionated Stereotactic Radiotherapy of Lung Cancers Using Gated 4D-CT Images (2006) (0)
Abstract 4862: Effect of irradiation and gold nanoparticle on expression dynamics of cell surface markers in MDA-MB 231 breast cancer cells (2019) (0)
Radiation-induced elevation in plasma TGF-beta1 during radiation therapy may be predictive of radiation-induced lung toxicity in patients with non-small cell lung cancer: A combined analysis from Beijing and Michigan: PD5-1-5 (2015) (0)
SU‐FF‐J‐70: Respiratory Gated Radiation Therapy Directly Using Patient's Fluoroscopic Images Instead of External Or Internal Markers (2005) (0)
SU-F-R-49: A Novel Kinetic Model for Prediction of Tumor Local Control for Patients with Lung Cancer. (2016) (0)
Gene – QOL consortium (2009) (0)
Potential Failure Modes for Magnetic Resonance–Only Treatment Planning in the Pelvis (2016) (0)
WE-AB-207B-09: Margin Reduction for Planning Target Volume (PTV) in Patients with Localized Prostate Cancer: Impact On Delivered Dose and Quality of Life. (2016) (0)
Dosimetric Variables Predicting for Acute Esophagitis During Definitive Radiation Therapy for Locally Advanced Non-Small Cell Lung Cancer—Results of a Large Prospective Observational Study (2016) (0)
1456: Recursive Partitioning Analysis of Predictors of Distant Metastasis for Men with Prostate Cancer Treated with Radiotherapy and Androgen Deprivation on RTOG 9202: The Impact of KI-67 (2004) (0)
The Projection Summing Optimization Algorithm Can Effectively Reduce Normal Brain Dose in Stereotactic Radiosurgery of Multiple Brain Metastases With Single Isocenter. (2016) (0)
SU‐FF‐T‐199: Dosimetry Validation for Spinal Cord Irradiation In Extracranial Stereotactic Radiosurgery (2006) (0)
Cardiac and pulmonary dosimetric parameters in lung cancer patients undergoing post-operative radiation therapy across a state-wide consortium. (2023) (0)
P-53 Phase I dose-escalation study of thoracic irradiation with concurrent chemotherapy for patients with limited small cell lung cancer (LSCLC). Radiation therapy oncology group (RTOG) protocol 9712 (2003) (0)
PO-BPC-Exhibit Hall-02 Intermediate Dose Calculation During Optimization Improves Plan Quality for Lung IMRT and SBRT - (2015) (0)
Cancer Management Chapter 4: Small-cell lung cancer, mesothelioma, and thymoma (2010) (0)
Stereotactic Radiosurgery vs Conventional Radiotherapy for Localized Vertebral Metastases of the Spine: Phase 3 Results of NRG Oncology/RTOG 0631 Randomized Clinical Trial. (2023) (0)
Statewide rates of adjuvant checkpoint inhibitor use after definitive chemoradiation for stage III non-small cell lung cancer. (2021) (0)
SU‐FF‐T‐560: Evaluation of ExacTrac and CBCT Patient Positioning On the Novalis TX (2009) (0)
Optimization of a Novel CBCT Estimation Method using Prior Information (2010) (0)
TH-A-137-10: Comprehensive Investigation of Dose Calculation for Lung Stereotactic Ablative Radiation (SABR): Effects of Tumor Size and Location and Clinical Recommendations. (2013) (0)
Failure Mode and Effects Analysis Applied to an In-House Incident Learning System (2014) (0)
TU‐C‐204B‐07: A Comparative Study for Daily Localization with 3D Ultrasound, Cone Beam CT, Implanted Prostate Fiducial Markers and Calypso 4D Localization System for Patients Undergoing IGRT for Prostate Cancer (2010) (0)
2749 : A Dosimetric Analysis of Actual RT Dose Delivered With or Without Margin Reduction in Prostate Cancer Patients Undergoing Daily Cone Beam CT (CBCT) (2006) (0)
Superiority of Radiomics Information Compared to Clinical Factors in Characterization of Human Papilloma Virus (HPV) Status in Patients With Oropharyngeal Squamous Cell Carcinomas. (2021) (0)
WE-AB-207B-12: Prospective Study of the Relationship Between Dose-Volume Clinical Toxicity and Patient Reported Outcomes in Lung Cancer Patients Treated with SBRT. (2016) (0)
MO‐D‐BRC‐01: Dosimetric Evaluation of a Novel Cone‐Beam CT (CBCT) Estimation Method Using Prior Information for Lung Cancer Patient Treatment (2011) (0)
(S038) Do Race or Income Influence Quality of Life (QOL) or Survival (OS) After Lung Stereotactic Body Radiotherapy (SBRT) in Stage I Non-Small Cell Lung Cancer? A Prospective Study (2017) (0)
Bevacizumab Use in Patients With Subtotal Resection of Newly Diagnosed Glioblastoma (GBM): A Secondary Analysis of NRG Oncology/RTOG 0825 (2015) (0)
Gene Therapy and Radiation (2011) (0)
A Prospective Study of the Dosimetric Impact and Quality of Life from Margin Reduction for Patients with Localized Prostate Cancer (2020) (0)
Dose-Escalated Radiotherapy Alone or in Combination With Short-Term Androgen Deprivation for Intermediate-Risk Prostate Cancer: Results of a Phase III Multi-Institutional Trial. (2023) (0)
MA06.10 A Pooled Analysis Comparing the Outcomes of Elderly to Younger Patients on NCTN Trials of Concurrent CCRT for Stage 3 NSCLC (2017) (0)
Improved target visualization using a novel iterative CBCT reconstruction algorithm for prostate cancer RT. (2018) (0)
Abstract 2816: BUB1 inhibition radiosensitizes triple-negative breast cancer by targeting the DNA-damage repair pathways (2023) (0)
A Prospective Analysis of Quality of Life Data and Clinical Toxicity as a Function of Radiation Dose and Volume in Stage I Lung Cancer Patients after SBRT (2020) (0)
SU‐FF‐J‐55: Treatment Verification for Lung Cancer Patients Undergoing Fractionated Stereotactic Body Radiation Therapy (SBRT) Utilizing Cone Beam CT (CBCT) (2007) (0)
A Spinal Cord Normal Tissue Complication Probability (NTCP) Model For Optimization Of Stereotactic Radiation Treatment Of Spine Metastasis (2011) (0)
Outcomes for Hormone-naïve Patients Who Achieved Undetectable PSA After Salvage Prostate Bed Radiation Treatment Postprostatectomy (2012) (0)
SU‐GG‐T‐515: The Influence of Longitudinal CT Resolution on Target Delineation and Treatment Planning for Stereotactic Radiosurgery (2010) (0)
An AI-based Issue Analyzing Framework for Clinical QA Workflow (2020) (0)
Prospective Study of Dominant Intraprostatic Lesion (DIL) Response Before, During, and Post Radiation Treatment using Multi-Parametric MRI Biomarkers (2019) (0)
A prospective phase II study of induction carboplatin and vinorelbine followed by concomitant topotecan and accelerated radiotherapy (RT) in locally advanced non-small cell lung cancer (NSCLC). (2006) (0)
SU‐FF‐T‐504: An Integrated Software Framework for Radiotherapy Research and Outcome Analysis for Stereotactic Body Radiotherapy (2009) (0)
Contouring Variability of Human and Deformable Generated Contours on Planning and Cone Beam CT Datasets in Radiation Therapy for Prostate Cancer (2015) (0)
TU‐A‐213CD‐11: A Synchronized Moving Grid (SMOG) to Detect and Correct Imaging Lag in Cone Beam Computed Tomography (CBCT): A Simulation Study (2012) (0)
Quantification of Cardiac Substructure Inter-fraction Displacement for MR-guided Radiation Therapy (2020) (0)
Feasibility of single fraction radiosurgery using a relocatable head frame: Dosimetric benefit from isocenter corrections using a CT scan in the treatment room (2004) (0)
Clinical Outcome in Patients With Early-Stage Small Cell Lung Cancer Treated With Surgery or Radiation in the Absence of Prophylactic Cranial Irradiation: A Single-Center Retrospective Study (2023) (0)
SU‐GG‐J‐100: Guidelines for Optimizing Image Quality and Minimizing Technique‐Specific Uncertainties in 3D Ultrasound Imaging for Online Image Guided Radiotherapy of the Prostate (2008) (0)
A NovelTreatment Approach (2015) (0)
A Phase 1b/2a Study Evaluating the Pharmacokinetics, Safety, and Efficacy of Nanogenistein in Combination with Chemoradiotherapy for Non-small Cell Lung Cancer (2020) (0)
3. Stage-directed treatment guidelines (1996) (0)
Quality-of-Life Data Provide Valuable Insights in Lung Cancer Patients (2017) (0)
Differences in Pattern of Practice in Radiation Therapy for Patients With Non-Small Cell Lung Cancer (NSCLC) Between Physicians in China and the United States (US) (2007) (0)
MO-D-105-07: Results of Applying FMEA and Fault Tree Analysis to the Online Incident Reporting Database. (2013) (0)
Stereotactic Body Radiation Therapy After Surgical Resection of Primary Lung Cancers (2014) (0)
Radiation and Gold Nanoparticle Increase the Expression of Immunogenic Cell Death Markers in MDA MB 231 Breast Cancer Model (2020) (0)
In Reply to Mell. (2015) (0)
Magnetic Resonance Guided Stereotactic Ablative Radiation Therapy vs. Chemoradiation for Borderline and Locally Advanced Pancreatic Cancer: Single Institution Overall Survival Comparison. (2021) (0)
Prostate Lesion Malignancy Classification from Multiparametric MRI Images Using Convolution Neural Network (2018) (0)
3115 Influence of the Couch and Immobilization Device used during Stereotactic Body Radiotherapy on Skin Dose (2009) (0)
A Novel Model to Predict the Overestimation of Pencil Beam Dose Calculation in Stereotactic Body Radiation Therapy of Lung Tumors (2011) (0)
Development of a patient-specific model for calculation of pulmonary function (2011) (0)
SU-F-J-38: Dose Rates and Preliminary Evaluation of Contouring Similarity Metrics Using 4D Cone Beam CT. (2016) (0)
Consensus Quality Measures and Dose Constraints for Breast Cancer from the Veterans Affairs Radiation Oncology Quality Surveillance Program and American Society for Radiation Oncology (ASTRO) Expert Panel. (2022) (0)
A Prospective Study Incorporating Magnetic Resonance Simulation into Treatment Planning for Prostate Cancer Patients: Correlation Between Dose and Early Quality of Life Indicators (2015) (0)
Do Race and Income Influence Quality of Life (QOL) or Survival Outcomes After Lung Stereotactic Body Radiation Therapy (SBRT)? A Prospective Study (2016) (0)
RADIATION THERAPY FOR SMALL-CELL LUNG CANCER (2012) (0)
ASTRO会议之SABR专场——"Stereotactic Radiation Therapy: Beyond Medical Inoperable Stage I NSCLC" (2015) (0)
ACR Appropriateness Criteria s Early-Stage Non–Small–Cell Lung Cancer early-stage non–small–cell lung cancer, medical oper- ability, surgery, radiotherapy, adjuvant (2014) (0)
PD5-1-4: Differences in pattern of practice in radiation therapy for patients with non-small cell lung cancer between physicians from the United States and Other Countries (2007) (0)
2306: Daily Volume Changes in Rectum and Bladder as Noted on Consecutive Pre-treatment Cone Beam CT Scans (CBCT) Performed During IMRT for Prostate Cancer (PC): Implications for Dose Volume Histograms (DVH) (2006) (0)
Toxicity and Efficacy of Replication-competent Adenovirus-mediated Suicide Gene Therapy with Radiation in a Preclinical Model of Glioma (2008) (0)
Potential for Sensitive Cardiac Substructure Sparing Using MR-guided Radiation Therapy (2019) (0)
Radiation and Gold Nanoparticle Immunomodulation in MDA MB 231 Mouse Breast Cancer Model (2020) (0)
A Study of Daily Localization with 3D Ultrasound, Cone Beam CT and Implanted Fiducial Markers for Patients undergoing IGRT for Prostate Cancer (2008) (0)
Radiomics Analysis of Normal Tissue for Patients with Lung Cancers (2018) (0)
TH-A-9A-07: Investigation of Localization Errors Using CBCT for SABR-Based Treatment of Lung Cancer and Impact On Planning Margins and Dose Coverage. (2014) (0)
A Potential Means of Investigating the Role of Luteinizing Hormone in the Pathogenesis ofAlzheimer Disease (2008) (0)
Improvement in Deformable Image Registration Accuracy Resulting from a Novel Scatter Reduction and Correction Method in Cone-beam CT Imaging (2010) (0)
Introduction: Personalization of Cancer Care for Older Adults. (2022) (0)
Three-dimensional wavelet decomposition-based radiomics analysis for tumor characterization in patients with oropharyngeal squamous cell carcinoma (2022) (0)
Differentially Dosed Stereotactic Body Radiation Therapy for the Treatment of Lung Cancer With Limited Nodal Metastasis in Patients Unable to Receive Chemotherapy (2013) (0)
A Novel Technique of Reconstructing Soft Tissue Enhanced Portal Images Using 2D/3D Image Fusion (2005) (0)
A Framework for Evaluation of Adaptive vs. Conventional Planning in IGRT of Prostate Cancer (2010) (0)
A Novel Multifield Grid Treatment Technique Using MLC-based IMRT (2012) (0)
CTNI-50. NEUROCOGNITIVE FUNCTION (NCF) OF THE PHOTON COHORT IN NRG-BN001 (2020) (0)
MR-Only Planning for Simultaneous Integrated Boost of MRI-defined Dominant Intraprostatic Lesions (2017) (0)
Dosimetric evaluation of synthetic CT relative to bulk density assignment-based magnetic resonance-only approaches for prostate radiotherapy (2015) (0)
Do Socio-Demographic Factors Affect Overall Survival in Patients With Unresectable Pancreatic Cancer?: Results of a Secondary Analysis of RTOG Data (2013) (0)
Optimal treatment planning of extracranial stereotactic conformal radiotherapy for medically inoperable lung cancer (2004) (0)
2062 : Image-Guided Spinal Radiosurgery for Epidural Compression of Multiple Myeloma (2006) (0)
Abstract2595: Is There a “Disconnect” Between Physician and Patient- Reported Outcomes (PROs): An Analysis of RTOG 98–01 (2006) (0)
2491 : Hypofractionated Stereotactic Body Radiotherapy (SBRT) for Medically Unresectable Stage I Non-Small Cell Lung Cancer (NSCLC) (2006) (0)
Radiomics Analysis and Unsupervised Self-Organizing-Map Technique to Predict Radiation-Induced Pneumonitis in Patients with Lung Cancer (2020) (0)
Evaluation of Stereotactic Body Radiation Therapy Pancreas Patient Plans Delivered Using Magnetic Resonance-Guided Radiotherapy (2019) (0)
To gate or not to gate - dosimetric evaluation comparing Gated vs. ITV-based methodologies in stereotactic ablative body radiotherapy (SABR) treatment of lung cancer (2016) (0)
Stage-directed treatment guidelines. (1996) (0)
Introduction. “small steps” in our battle with SCLC. (2012) (0)
Cardiac and Pulmonary Dosimetric Parameters in Lung Cancer Patients Undergoing Post-Operative Radiation Therapy in the Real-World Setting (2022) (0)
Dosimetric Analysis of Lung Cancer Treatment Planning for Stereotactic Body Radiation Therapy Utilizing Cone Beam CT (2007) (0)
Patient reported outcomes and unscheduled health services use during oral anti-cancer treatment. (2022) (0)
SU‐FF‐J‐125: Fractionated Stereotactic Body Radiation Therapy (SBRT) of Lung Tumors — 4DCT Simulation with An AcQSim CT and Varian's RPM System (2007) (0)
Radiation Dose Escalation Reduces Distant Metastasis and Increases Survival for Men with Prostate Cancer: 10:22 PM (28) (2002) (0)
Randomized Phase III, Double-Blind, Placebo-Controlled Study of Prophylactic Gabapentin for the Reduction of Radiation Therapy-Induced Pain During the Treatment of Oropharyngeal Squamous Cell Carcinoma. (2021) (0)
Patient-Reported Outcomes (PROs) in NRG Oncology RTOG 1010: Phase III Trial Evaluating the Addition of Trastuzumab to Trimodality Treatment of HER2 Overexpressing (HER2+) Esophageal Adenocarcinoma (EAC) (2022) (0)
SU‐FF‐J‐41: Clinical Management of Detected Target Deviations in IGRT: A Geometrical Approach (2009) (0)
Reassessing Prognostic Factors in the Era of Combined Modality Therapy for Locally Advanced NSCLC: A Retrospective Analysis of RTOG 9410 and 9801 (2005) (0)
SU‐FF‐T‐190: Daily Quality Assurance (QA) Procedure of On‐Board Imager (OBI) (2005) (0)
ACR Appropriateness Criteria s Early-Stage Non-Small-Cell Lung Cancer (2014) (0)
Permanent Source Brachytherapy for Prostate Cancer (2016) (0)
SU-F-R-38: Impact of Smoothing and Noise On Robustness of CBCT Textural Features for Prediction of Response to Radiotherapy Treatment of Head and Neck Cancers. (2016) (0)
MR-only planning for simultaneous integrated boost of multi-modal MRI-defined dominant intraprostatic lesions. (2018) (0)
A Web-based Database for Outcomes Study for Lung Stereotactic Body Radiotherapy (2010) (0)
Calendar of Events (2012) (0)
American Radium Society® (ARS) Appropriate Use Criteria on Radiation Therapy in Oligometastatic or Oligoprogressive Non-Small Cell Lung Cancer (NSCLC) (2020) (0)
Completion of electronic patient reported outcome measures among diverse cancer patients treated in an integrated health system. (2022) (0)
Effect of Irradiation and Gold Nanoparticle on Expression Dynamics of Cell Surface Markers in MDA-MB 231 Breast Cancer Cells (2019) (0)
Toward a Noninvasive Measurement of Cancer Stem Cells and Tumor Aggressiveness (2016) (0)
Locally advanced non-small cell lung cancer: the "local" issue. (1996) (0)
Predictors of early hospice or death in patients with inoperable lung cancer treated with curative intent. (2021) (0)
Cancer Management Chapter 3: Non–small-cell lung cancer (2010) (0)
MO‐E‐BRB‐06: Using Generalized Equivalent Uniform Dose to Evaluate Dose Distributions in NSCLC Patients Planned for Stereotactic Body Radiotherapy (2010) (0)
How Often Are Previously Undetected Radiographic Abnormalities Detected at the Time of CT Simulation (2007) (0)
P033) Do Sociodemographic Factors and Comorbidities Significantly Influence Outcome in Prostate Cancer Patients Treated With External Beam Radiation Therapy (2017) (0)
SU-FF-T-212: Quality Assurance (QA) Procedure of On-Board Imager (OBI) for Portal Imaging (2005) (0)
114 : A Phase II Trial of Concurrent Paclitaxel and Carboplatin and Thoracic Radiotherapy in Resected Stage II and IIIA Non-Small Cell Lung Carcinoma (2006) (0)
Feasibility of radical cardiac‐sparing, treatment planning strategies for patients with locally advanced, non‐small cell lung cancer (2022) (0)
SU‐GG‐T‐113: Using Probability Density Functions of Respiratory Motion to Model Motion Effects On Dose Distributions and Optimize Treatment Planning for Lung Cancers (2008) (0)
Quality of Life Outcomes in Radiotherapy of Lung Cancer (2011) (0)
Abstract 1376: Effect of gold nanoparticle on radiation induced DNA damage in MCF7 breast cancer cells (2018) (0)
Does Socioeconomic Status (SES) Influence Outcome in Prostate Cancer Patients Treated with External Beam Radiation Therapy (EBRT) (2009) (0)
Gender, Professional Experiences, and Personal Characteristics of Academic Radiation Oncology Chairs (2018) (0)
Online Evaluation of Daily Pre-treatment Cone Beam CT Scans (CBCT) during IMRT for Prostate Cancer (PC): Dietary Advice and Correction of Rectal Filling (RF) when Necessary - may Decrease ≥ Grade 2 Rectal Toxicity (2008) (0)
MO‐D‐BRC‐06: A Multi‐Exposure Approach to Improve Image Quality for Linac‐Based Cone Beam Computed Tomography (CBCT) (2011) (0)
Dosimetric Evaluation and Optimization of a Novel CBCT Estimation Method for Adaptive Radiation Therapy (ART) (2011) (0)
Correlation of Dose with Patterns of Failure following SABR-based Treatment of NSCLC (2011) (0)
SU‐FF‐J‐21: An External‐Marker Based Non‐Respiratory Body Motion Monitoring System (2006) (0)
Radiosurgical Decompression of Malignant Epidural Spinal Cord Compression (2007) (0)
Patterns of Missing Mini Mental Status Exam Data in Radiation Therapy Oncology Group (RTOG) Brain Tumor Trials (2008) (0)
Role of adjuvant therapy in resected stage II/IIIA non-small-cell lung cancer. (2001) (0)
Phase II trial of cisplatin (C), etoposide (E) and radiation (RT) followed by gemcitabine (G) vs G and docetaxel (D) in stage III A/B unresectable non-small cell lung cancer (NSCLC). (2006) (0)
Can We Use TCP to Predict Tumor Local Control (2013) (0)
Automatic Prediction of 3D Radiation Dose Distribution in Prostate Cancer Treated with Volumetric Modulated Arc Therapy (VMAT) Using a Conditional Generative Adversarial Network (cGAN). (2021) (0)
Prospective Evaluation of Limited-Stage Small Cell Lung Cancer Radiotherapy Fractionation Regimen Usage and Acute Toxicity in a Large Statewide Quality Collaborative. (2023) (0)
Dose-Escalated Radiation Alone or in Combination With Short-Term Total Androgen Suppression for Intermediate-Risk Prostate Cancer: Patient-Reported Outcomes From NRG/Radiation Therapy Oncology Group 0815 Randomized Trial. (2023) (0)
Assessment of Differences in Academic Rank and Compensation by Gender and Race/Ethnicity Among Academic Radiation Oncologists in the United States (2023) (0)
Deriving radiomics features from CT images using a partial least square correlation technique in the lung cancer setting. (2017) (0)
Gold nanoparticle radio-sensitization of MCF-7 breast cancer cells. (2017) (0)
1011 Evidence for increased failure in patients with perineural invasion treated with three-dimensional conformal radiation therapy (1996) (0)
Association between lung density changes and radiation pneumonitis after IMRT for lung cancer. (2018) (0)
Co-morbidities Affect Cancer Treatment Strategies And Outcome In Patients With Locally Advanced Non-small Cell Lung Cancer (NSCLC): Report Of Quality Research In Radiation Oncology (QRRO) Data For Stage III NSCLC Patients (2011) (0)
655MO Quality of life in patients with p16+ oropharyngeal cancer receiving accelerated radiotherapy (RT) with either cisplatin or cetuximab in NRG/RTOG 1016 (2022) (0)
Practice type & race influence enrollment onto clinical oncology trials: A Patterns of Care Study analysis. (2004) (0)
Initial clinical experience with a radiation oncology dedicated open 10T MR-simulation (2021) (0)
2295 Quality of life (FACT-C) scores remain at baseline following conformal radiotherapy for prostate cancer: A prospective study (1999) (0)
2112 Long-Term Results of Proton Beam Therapy for Surgically Inaccessible or Residual Meningiomas (2007) (0)
PATTERNS OF PRACTICE IN LIMITED-STAGE SMALL CELL LUNG CANCER (LS-SCLC) AMONG RADIATION ONCOLOGISTS (2007) (0)
Investigating the clinical utility of gafchromic ebt3 film dosimetry in an MR-guided linac. (2018) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Benjamin Movsas?

Benjamin Movsas is affiliated with the following schools:

Medical College of Wisconsin
Johns Hopkins University
University of Toronto
Temple University
Thomas Jefferson University
University of Pennsylvania

Benjamin Movsas's Academic­Influence.com Rankings

Why Is Benjamin Movsas Influential?

Benjamin Movsas's Published Works

Published Works

What Schools Are Affiliated With Benjamin Movsas?

Benjamin Movsas's AcademicInfluence.com Rankings